<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6808808/results/search/country/results.xml">
   <result pre="sits at the epicenter of the HIV epidemic in the" exact="United States" post="and harbors 54 of the top 220 HIV/HCV outbreak"/>
   <result pre="of the top 220 HIV/HCV outbreak vulnerable counties in the" exact="United States;" post="44 of which are served by the Bluegrass Care"/>
   <result pre="the work toward the eventual elimination of HIV in the" exact="United States" post="and elsewhere. Methods The Bluegrass Care Clinic has achieved"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6810139/results/search/country/results.xml">
   <result pre="Abstracts 2585. Changing Epidemiological Profile of Infantile Parechovirus-A3 Infection in" exact="Japan" post="AizawaYutaMD, PhD1IzumitaRyoheiMD, PhD1YamanakaTakayukiMD2HabukaRieMD1IkuseTatsukiMD1WatanabeKanakoPhD1OtsukaTaketoMD, PhD1SaitohAkihikoMD, PhD1[1], Niigata UniversityJapan[2], Niigata City"/>
   <result pre="young infants. The first case of PeV-A3 was reported in" exact="Japan" post="in 1999 and, although epidemics have been reported every"/>
   <result pre="more than 20 countries, no major epidemic has occurred in" exact="Japan" post="since 2014. Methods This prospective study included febrile infants"/>
   <result pre="future study should investigate if this trend has continued in" exact="Japan" post="and other countries and identify the causes of this"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6897431/results/search/country/results.xml">
   <result pre="Physical Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California," exact="United States" post="of America[2], Department of Pathology, Microbiology and Immunology, School"/>
   <result pre="School of Veterinary Medicine, University of California Davis, Davis, California," exact="United States" post="of America[3], California National Primate Research Center, University of"/>
   <result pre="National Primate Research Center, University of California Davis, Davis, California," exact="United States" post="of America[4], Computations Directorate, Lawrence Livermore National Laboratory, Livermore,"/>
   <result pre="of America[4], Computations Directorate, Lawrence Livermore National Laboratory, Livermore, California," exact="United States" post="of AmericaKhudyakovYury EEditor[], Centers for Disease Control and Prevention,"/>
   <result pre="until 2015 when a large outbreak of ZIKV infections in" exact="Brazil" post="was linked to a dramatic increase in microcephaly cases"/>
   <result pre="the genome of ZIKV as the Asian lineage spread from" exact="French Polynesia" post="to Haiti and Brazil, and then to other countries"/>
   <result pre="ZIKV as the Asian lineage spread from French Polynesia to" exact="Haiti" post="and Brazil, and then to other countries in South,"/>
   <result pre="not known if Asian lineage strains circulating prior to the" exact="French Polynesia" post="outbreak are capable of causing microcephaly in humans, genomes"/>
   <result pre="outbreak are capable of causing microcephaly in humans, genomes from" exact="Thailand" post="2006, Cambodia 2010, Philippines 2012, and Thailand 2013 are"/>
   <result pre="capable of causing microcephaly in humans, genomes from Thailand 2006," exact="Cambodia" post="2010, Philippines 2012, and Thailand 2013 are included in"/>
   <result pre="causing microcephaly in humans, genomes from Thailand 2006, Cambodia 2010," exact="Philippines" post="2012, and Thailand 2013 are included in the analysis"/>
   <result pre="humans, genomes from Thailand 2006, Cambodia 2010, Philippines 2012, and" exact="Thailand" post="2013 are included in the analysis as &quot;pre-emergent strains&quot;"/>
   <result pre="with the later Asian genomes associated with epidemic. Asian strain" exact="Malaysia" post="1966 was used as a distant progenitor for comparison"/>
   <result pre="Gene Residue AA Year N/Year Thail Cambo Indon Phili FrPol" exact="Haiti" post="Brazi FrGui Surin Colom Panam Hondu Guate Mexic PuRic"/>
   <result pre="- Nt Codon Gene Residue AA Year N/Year Venez Ecuad" exact="Peru" post="Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa"/>
   <result pre="N/Year Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti" exact="Cuba" post="Fiji Samoa Tonga Impor 473 GCG Pr 1 A"/>
   <result pre="Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba" exact="Fiji" post="Samoa Tonga Impor 473 GCG Pr 1 A 2006"/>
   <result pre="Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji" exact="Samoa" post="Tonga Impor 473 GCG Pr 1 A 2006 0"/>
   <result pre="Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa" exact="Tonga" post="Impor 473 GCG Pr 1 A 2006 0 -"/>
   <result pre="Gene Residue AA Year N/Year Thail Cambo Indon Phili FrPol" exact="Haiti" post="Brazi FrGui Surin Colom Panam Hondu Guate Mexic PuRic"/>
   <result pre="- Nt Codon Gene Residue AA Year N/Year Venez Ecuad" exact="Peru" post="Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa"/>
   <result pre="N/Year Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti" exact="Cuba" post="Fiji Samoa Tonga Impor 2786 GCT NS1 100 A"/>
   <result pre="Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba" exact="Fiji" post="Samoa Tonga Impor 2786 GCT NS1 100 A 2006"/>
   <result pre="Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji" exact="Samoa" post="Tonga Impor 2786 GCT NS1 100 A 2006 0"/>
   <result pre="Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa" exact="Tonga" post="Impor 2786 GCT NS1 100 A 2006 0 -"/>
   <result pre="Gene Residue AA Year N/Year Thail Cambo Indon Phili FrPol" exact="Haiti" post="Brazi FrGui Surin Colom Panam Hondu Guate Mexic PuRic"/>
   <result pre="- Nt Codon Gene Residue AA Year N/Year Venez Ecuad" exact="Peru" post="Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa"/>
   <result pre="N/Year Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti" exact="Cuba" post="Fiji Samoa Tonga Impor 5810 CAT NS3 400 H"/>
   <result pre="Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba" exact="Fiji" post="Samoa Tonga Impor 5810 CAT NS3 400 H 2006"/>
   <result pre="Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji" exact="Samoa" post="Tonga Impor 5810 CAT NS3 400 H 2006 1"/>
   <result pre="Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa" exact="Tonga" post="Impor 5810 CAT NS3 400 H 2006 1 -"/>
   <result pre="Gene Residue AA Year N/Year Thail Cambo Indon Phili FrPol" exact="Haiti" post="Brazi FrGui Surin Colom Panam Hondu Guate Mexic PuRic"/>
   <result pre="- Nt Codon Gene Residue AA Year N/Year Venez Ecuad" exact="Peru" post="Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa"/>
   <result pre="N/Year Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti" exact="Cuba" post="Fiji Samoa Tonga Impor 8006 ATG NS5 114 M"/>
   <result pre="Venez Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba" exact="Fiji" post="Samoa Tonga Impor 8006 ATG NS5 114 M 2006"/>
   <result pre="Ecuad Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji" exact="Samoa" post="Tonga Impor 8006 ATG NS5 114 M 2006 1"/>
   <result pre="Peru Nicar Guade DoRep USA Jamai Marti Cuba Fiji Samoa" exact="Tonga" post="Impor 8006 ATG NS5 114 M 2006 1 -"/>
   <result pre="(but not 114Met), Ile322Val, and Asp878Glu, were first detected in" exact="Haiti" post="and not detected in French Polynesia in 2013 or"/>
   <result pre="Asp878Glu, were first detected in Haiti and not detected in" exact="French Polynesia" post="in 2013 or in any of the pre-epidemic strains"/>
   <result pre="al, 2016 [33], which indicated that ZIKV was circulating in" exact="Haiti" post="in 2013, prior to emergence in Brazil. Three of"/>
   <result pre="322Val and 878Glu, were detected in relatively low numbers in" exact="Brazil" post="but subsequently became more abundant in the Dominican Republic"/>
   <result pre="numbers in Brazil but subsequently became more abundant in the" exact="Dominican Republic" post="and USA. In addition to these genotypes being highly"/>
   <result pre="and were all detected in one or more samples from" exact="Cuba" post="2017. In the case of NS5 residue 114, Table"/>
   <result pre="2015. Cluster 1.1 consisting of ~100 genomes (mostly Haiti, Brazil," exact="Dominican Republic," post="and USA—Florida) is characterized by one additional 2014 mutation:"/>
   <result pre="Thr833Ala. And finally, the Cluster 1.4 (~100 genomes; mostly Brazil," exact="Puerto Rico," post="and Venezuela) can be defined based on the absence"/>
   <result pre="residues at these positions as observed in the ancestral 1966" exact="Malaysia" post="strain. Other mutations that were detected early in the"/>
   <result pre="after passage in vivo. A 2015 strain of ZIKV from" exact="Brazil" post="(strain ZIKV/H.sapiens-tc/BRA/2015/Brazil_SPH2015, KU321639.1) was analyzed prior to and after"/>
   <result pre="obtained for a 2015 strain, PRVABC59 (accession # KU501215), from" exact="Puerto Rico" post="before and after passage in mice dosed with Ifnar1"/>
   <result pre="fluid samples, days 2 and 7, as well as the" exact="Brazil" post="2015 GenBank reference sequence (accession # KU321639), thus were"/>
   <result pre="1.2%) as well as in the sequence data from the" exact="French Polynesia" post="strain (2.2%) in the SRA (Bioproject PRJNA316976). Variants that"/>
   <result pre="Data from Univ. of Wisconsin Bioproject PRJNA413108 shows that a" exact="Puerto Rico" post="ZIKV laboratory strain has 37Leu at 17% and the"/>
   <result pre="sequence in five of these samples. One consensus sequence from" exact="Puerto Rico" post="2015 also had a Gly mutation present at this"/>
   <result pre="mutations, Asp393Glu and Thr487Met, first observed in pre-emergent samples from" exact="Thailand" post="in 2006, Cambodia in 2010, Philippines in 2012 and"/>
   <result pre="Thr487Met, first observed in pre-emergent samples from Thailand in 2006," exact="Cambodia" post="in 2010, Philippines in 2012 and French Polynesia in"/>
   <result pre="in pre-emergent samples from Thailand in 2006, Cambodia in 2010," exact="Philippines" post="in 2012 and French Polynesia in 2013. (C) Homodimer"/>
   <result pre="Thailand in 2006, Cambodia in 2010, Philippines in 2012 and" exact="French Polynesia" post="in 2013. (C) Homodimer conformation of the NS1 protein"/>
   <result pre="respectively (Fig 1, Table 2). Mutation Tyr122His first detected in" exact="Haiti" post="2014 and Brazil 2015, and a group of three"/>
   <result pre="Table 2). Mutation Tyr122His first detected in Haiti 2014 and" exact="Brazil" post="2015, and a group of three exposed mutations and"/>
   <result pre="the interface with NS5, and His355Tyr mutation first detected in" exact="Haiti" post="2014, Brazil 2015, and not detected in French Polynesia."/>
   <result pre="with NS5, and His355Tyr mutation first detected in Haiti 2014," exact="Brazil" post="2015, and not detected in French Polynesia. (E) NS5"/>
   <result pre="detected in Haiti 2014, Brazil 2015, and not detected in" exact="French Polynesia." post="(E) NS5 protein showing critical outbreak mutation 114Val (forms"/>
   <result pre="at 3.5% in data from a macaque infected with the" exact="French Polynesia" post="strain from Bioproject PRJNA316976. Similarly, at NS1 residue 264"/>
   <result pre="residue1058), there is a change from Val to Met in" exact="Thailand" post="2006 and Cambodia 2010, and Met is present as"/>
   <result pre="a change from Val to Met in Thailand 2006 and" exact="Cambodia" post="2010, and Met is present as consensus in samples"/>
   <result pre="consensus in samples from pre-epidemic and epidemic cases, whereas the" exact="Malaysia" post="strain has Val (S2 Table). However, Val is still"/>
   <result pre="epidemic. Val is detected at 4.2% in Illumina data from" exact="French Polynesia" post="stock virus (Bioproject PRJNA316976) and maintained during passage in"/>
   <result pre="(polyprotein residue 1118) was observed in a single sample from" exact="Brazil" post="but spread extensively to other countries during the outbreak,"/>
   <result pre="spread extensively to other countries during the outbreak, in particular" exact="Colombia" post="as shown in Cluster 1.3 and Table 2. A"/>
   <result pre="in an infected macaque at 6.5%, but not in the" exact="French Polynesia" post="stock used to initiate the infection. Protein structure analysis"/>
   <result pre="epidemic strains. For example, strains from Africa, Malaysia, Cambodia, and" exact="French Polynesia" post="have Met349 as consensus, whereas 2014 strains from Haiti"/>
   <result pre="French Polynesia have Met349 as consensus, whereas 2014 strains from" exact="Haiti" post="have either Met or Val, as do outbreak strains"/>
   <result pre="has been associated with at least 4 microcephaly cases (3" exact="Brazil" post="2015 and 1 Cuba 2017) [4,32,45]. Deep sequence data"/>
   <result pre="at least 4 microcephaly cases (3 Brazil 2015 and 1" exact="Cuba" post="2017) [4,32,45]. Deep sequence data show that this residue"/>
   <result pre="For example, analysis of the Illumina data from the 2013" exact="French Polynesia" post="strain (Univ. of Wisconsin Bioproject PRJNA316976) show a Thr"/>
   <result pre="passage in macaques. Our data from macaque passage of the" exact="Brazil" post="2015 strain (accession # KU321639) shows Met349Lys at 7.4%"/>
   <result pre="5). Interestingly, Illumina deep sequence data available from a 2013" exact="French Polynesia" post="strain also showed a Met32Ile mutation detected at 5%"/>
   <result pre="was of particular interest as it was first detected in" exact="Thailand" post="and French Polynesia in 2013 and was maintained throughout"/>
   <result pre="particular interest as it was first detected in Thailand and" exact="French Polynesia" post="in 2013 and was maintained throughout the epidemic, thus"/>
   <result pre="also predicted to be antigenic. It was first detected in" exact="Cambodia" post="in 2010 and thus was circulating well before the"/>
   <result pre="groups: unassociated with the recent emergence of ZIKV (Asian strain" exact="Malaysia" post="1966 (accession # KX377336)), &quot;pre-emergent strains&quot;, and Asian genomes"/>
   <result pre="residue information, and data from protein structural analysis. Asian strain" exact="Malaysia" post="1966 (accession # KX377336) was used as a distant"/>
   <result pre="Institute and was originally isolated from a transfusion recipient in" exact="Brazil" post="in 2015. This strain was passaged 3 times in"/>
   <result pre="al. (2017) Establishment and cryptic transmission of Zika virus in" exact="Brazil" post="and the Americas. Nature546: 40610.1038/nature2240128538727 33LednickyJ, Beau De RocharsVM,"/>
   <result pre="LoebJ, TelismaT, ChavannesS, et al. (2016) Zika Virus Outbreak in" exact="Haiti" post="in 2014: Molecular and Clinical Data. PLoS Neglected Tropical"/>
   <result pre="cDNA Clone of Zika Virus from the 2015 Epidemic in" exact="Brazil" post="as a Genetic Platform for Studies of Virus-Host Interactions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6903426/results/search/country/results.xml">
   <result pre="9000 patients with viral load at least 1000 copies/ml in" exact="Guinea" post="and Burundi made it possible to obtain a viral"/>
   <result pre="with viral load at least 1000 copies/ml in Guinea and" exact="Burundi" post="made it possible to obtain a viral load less"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6961731/results/search/country/results.xml">
   <result pre="health and interventions to reduce perinatal HIV transmission in the" exact="United States." post="[accessed 2019 Dec 14]. Available from:http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. [22]BaileyH, ZashR, RasiV,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6964091/results/search/country/results.xml">
   <result pre="Health Emergencies programme, [2], 0000 0001 0155 5938grid.33058.3dPopulation Health Unit," exact="Kenya" post="Medical Research Institute - Wellcome Trust Research Programme, [3],"/>
   <result pre="Ebola virus disease (EVD) epidemic in the Democratic Republic of" exact="Congo" post="(DRC), the 2013–2016 EVD epidemic in West Africa and"/>
   <result pre="in West Africa and the humanitarian crisis in Northern Nigeria," exact="South Sudan," post="DRC, Central African Republic(CAR) and Mali are poignant reminders"/>
   <result pre="in Northern Nigeria, South Sudan, DRC, Central African Republic(CAR) and" exact="Mali" post="are poignant reminders of the local and global threat"/>
   <result pre="example, the EVD epidemic in West Africa – in Liberia," exact="Guinea" post="and Sierra Leone in 2013–2016 – had a huge"/>
   <result pre="EVD epidemic in West Africa – in Liberia, Guinea and" exact="Sierra Leone" post="in 2013–2016 – had a huge negative impact on"/>
   <result pre="available at the Office of Foreign Disaster Assistance(OFDA) of the" exact="United States" post="or the CRED International Disaster Database and can be"/>
   <result pre="in 1994 by the Federation of American Scientists and the" exact="United Kingdom" post="Space Agency-SATELLIFE, to provide up-to-date information on outbreaks of"/>
   <result pre="humanitarian crises (Fig. 5). Five countries (the DRC, Kenya, Nigeria," exact="South Sudan" post="and Uganda) reported over 15 public health events during"/>
   <result pre="crises (Fig. 5). Five countries (the DRC, Kenya, Nigeria, South" exact="Sudan" post="and Uganda) reported over 15 public health events during"/>
   <result pre="for health security (NAPHS) to address the identified gaps [18]." exact="Nigeria" post="and Uganda are two practical examples of countries showing"/>
   <result pre="security (NAPHS) to address the identified gaps [18]. Nigeria and" exact="Uganda" post="are two practical examples of countries showing the benefits"/>
   <result pre="thus reducing the scale and length of epidemics [21]. Similarly," exact="Nigeria" post="is strengthening implementation of the IHR. In 2016, the"/>
   <result pre="Nigeria is strengthening implementation of the IHR. In 2016, the" exact="Nigeria" post="Centre for Disease Control (NCDC) was established and has"/>
   <result pre="to be rare, have recently caused major epidemics in Liberia," exact="Guinea" post="and Sierra Leone (2013–2016) [28–31], in Uganda (2017 and"/>
   <result pre="rare, have recently caused major epidemics in Liberia, Guinea and" exact="Sierra Leone" post="(2013–2016) [28–31], in Uganda (2017 and 2018) [32, 33],"/>
   <result pre="epidemics in Liberia, Guinea and Sierra Leone (2013–2016) [28–31], in" exact="Uganda" post="(2017 and 2018) [32, 33], and in the Democratic"/>
   <result pre="in Uganda (2017 and 2018) [32, 33], and in the" exact="Democratic Republic of the Congo" post="(2018 and 2019) [34–37]. A 2016 comprehensive regional risk"/>
   <result pre="2018) [32, 33], and in the Democratic Republic of the" exact="Congo" post="(2018 and 2019) [34–37]. A 2016 comprehensive regional risk"/>
   <result pre="17 countries in the African region and countries, such as" exact="Chad" post="and Zambia, where Cholera epidemics were rare prior to"/>
   <result pre="evident that several countries in tier 1 such as the" exact="Democratic Republic of the Congo" post="(DRC), Kenya, Uganda, South Sudan also witnessed more humanitarian"/>
   <result pre="in tier 1 such as the Democratic Republic of the" exact="Congo" post="(DRC), Kenya, Uganda, South Sudan also witnessed more humanitarian"/>
   <result pre="as the Democratic Republic of the Congo (DRC), Kenya, Uganda," exact="South Sudan" post="also witnessed more humanitarian crisis events than other countries"/>
   <result pre="the Democratic Republic of the Congo (DRC), Kenya, Uganda, South" exact="Sudan" post="also witnessed more humanitarian crisis events than other countries"/>
   <result pre="7 million in Eswatini to USD 700 million in the" exact="Democratic Republic of the Congo" post="(DRC). The region-wide estimate is approximately USD 7–8 billion"/>
   <result pre="to USD 700 million in the Democratic Republic of the" exact="Congo" post="(DRC). The region-wide estimate is approximately USD 7–8 billion"/>
   <result pre="for International Development (United Kingdom) DON Disease Outbreak News DRC" exact="Democratic Republic of the Congo" post="EM-DAT Emergency Events Database EVD Ebola Virus Disease GIDEON"/>
   <result pre="Kingdom) DON Disease Outbreak News DRC Democratic Republic of the" exact="Congo" post="EM-DAT Emergency Events Database EVD Ebola Virus Disease GIDEON"/>
   <result pre="and acknowledges the support of the Wellcome Trust to the" exact="Kenya" post="Major Overseas Programme (number 203077). The funding sources had"/>
   <result pre="Regulations (2005), Third Edition. http://apps.who.int/iris/bitstream/10665/246107/1/9789241580496-eng.pdf?ua=1. 4.Centres for Disease Control (CDC)," exact="United States." post="www.cdc.gov/csels/dsepd/ss1978/lesson1/section11.html. Accessed 9 Dec 2019. 5.United Nations Office for"/>
   <result pre="countries avoid major economic loss but impact on Guinea, Liberia," exact="Sierra Leone" post="Remains Crippling, 2015. http://www.worldbank.org/en/news/press-release/2015/01/20/ebola-most-african-countries-avoid-major-economic-loss-but-impact-on-guinea-liberia-sierra-leone-remains-crippling. Accessed 3 Mar 2019. 18.World"/>
   <result pre="Infect Dis20181837337510.1016/S1473-3099(18)30164-629582758 22.Ike-Obioha J. How the monkey pox outbreak in" exact="Nigeria" post="could be curtailed. http://venturesafrica.com/how-the-monkeypox-outbreak-can-be-curtailed-in-nigeria/. Accessed 22 Feb 2019. 23.Nigeria"/>
   <result pre="Accessed 22 Feb 2019. 23.Nigeria Centers for Disease Control (NCDC)." exact="Nigeria" post="monkey pox outbreak report 027: November 13, 2018. Nigeria"/>
   <result pre="(NCDC). Nigeria monkey pox outbreak report 027: November 13, 2018." exact="Nigeria" post="Centre for disease control. Abuja, Nigeria. Retrieved February 26,"/>
   <result pre="6 Mar 2019. 35.WHO. Ebola strikes big city in the" exact="Democratic Republic of the Congo" post="and WHO scales up response to new threat -"/>
   <result pre="Ebola strikes big city in the Democratic Republic of the" exact="Congo" post="and WHO scales up response to new threat -"/>
   <result pre="Congo and WHO scales up response to new threat -" exact="Democratic Republic of the Congo." post="Brazzaville, 2018. (https://reliefweb.int/report/democratic-republic-congo/ebola-strikes-big-city-democratic-republic-congo-and-who-scales. Accessed 27 Feb 2019. 36.WHO. Ebola"/>
   <result pre="2018. (https://reliefweb.int/report/democratic-republic-congo/ebola-strikes-big-city-democratic-republic-congo-and-who-scales. Accessed 27 Feb 2019. 36.WHO. Ebola response in" exact="Democratic Republic of the Congo" post="risks slowdown. Geneva, 2019;. (https://www.who.int/news-room/detail/26-02-2019-ebola-response-in-democratic-republic-of-the-congo-risks-slowdown). Accessed 27 Feb 2019."/>
   <result pre="Feb 2019. 36.WHO. Ebola response in Democratic Republic of the" exact="Congo" post="risks slowdown. Geneva, 2019;. (https://www.who.int/news-room/detail/26-02-2019-ebola-response-in-democratic-republic-of-the-congo-risks-slowdown). Accessed 27 Feb 2019."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6971860/results/search/country/results.xml">
   <result pre="the causative virus of the dengue outbreak in Vietnam and" exact="Cambodia" post="from 2006 to 2008. These results indicated that DENV-1"/>
   <result pre="NS4B, and NS5 of DENV-1 circulating in Vietnam (2005, 2008)," exact="Thailand" post="(2010), Myanmar (2002), Brunei (2006), Cambodia (2008), China (2017),"/>
   <result pre="NS5 of DENV-1 circulating in Vietnam (2005, 2008), Thailand (2010)," exact="Myanmar" post="(2002), Brunei (2006), Cambodia (2008), China (2017), and Brazil"/>
   <result pre="in Vietnam (2005, 2008), Thailand (2010), Myanmar (2002), Brunei (2006)," exact="Cambodia" post="(2008), China (2017), and Brazil (2010) were obtained from"/>
   <result pre="(2005, 2008), Thailand (2010), Myanmar (2002), Brunei (2006), Cambodia (2008)," exact="China" post="(2017), and Brazil (2010) were obtained from the GenBank"/>
   <result pre="(2010), Myanmar (2002), Brunei (2006), Cambodia (2008), China (2017), and" exact="Brazil" post="(2010) were obtained from the GenBank nucleotide sequence database"/>
   <result pre="The similarities also disappeared with the strains that circulated in" exact="Cambodia" post="and Thailand. Genome distance estimation The similarities between the"/>
   <result pre="and 2008 (distance, 0.013–0.017), followed by DENV1 strains circulating in" exact="Cambodia" post="in 2006, 2008, and Thailand in 2001 (distance, 0.018–0.021),"/>
   <result pre="by DENV1 strains circulating in Cambodia in 2006, 2008, and" exact="Thailand" post="in 2001 (distance, 0.018–0.021), and other DENV1 strains in"/>
   <result pre="DENV1 strains causing diseases in some neighboring countries, such as" exact="China" post="(2006), Indonesia (1998), Brunei (2005, 2006), Malaysia (1972), Singapore"/>
   <result pre="causing diseases in some neighboring countries, such as China (2006)," exact="Indonesia" post="(1998), Brunei (2005, 2006), Malaysia (1972), Singapore (2004, 2013),"/>
   <result pre="countries, such as China (2006), Indonesia (1998), Brunei (2005, 2006)," exact="Malaysia" post="(1972), Singapore (2004, 2013), and Myanmar (1976), revealed very"/>
   <result pre="as China (2006), Indonesia (1998), Brunei (2005, 2006), Malaysia (1972)," exact="Singapore" post="(2004, 2013), and Myanmar (1976), revealed very high distances"/>
   <result pre="(1998), Brunei (2005, 2006), Malaysia (1972), Singapore (2004, 2013), and" exact="Myanmar" post="(1976), revealed very high distances with the strains of"/>
   <result pre="D1) revealed a lower similarity to the DENV1 strains from" exact="Japan" post="and Myanmar (yellow). Moreover, there seemed to be a"/>
   <result pre="a lower similarity to the DENV1 strains from Japan and" exact="Myanmar" post="(yellow). Moreover, there seemed to be a significant difference"/>
   <result pre="a significant difference with the strains from Brunei, Indonesia, China," exact="Malaysia" post="and Singapore (orange-red) although these countries are in Southeast"/>
   <result pre="difference with the strains from Brunei, Indonesia, China, Malaysia and" exact="Singapore" post="(orange-red) although these countries are in Southeast Asia. The"/>
   <result pre="difference with the strain from American such as Brazil, Colombia," exact="Mexico" post="(red). However, the sequence of D1 samples almost coincided"/>
   <result pre="to the group of DENV-1 from Vietnam (2007 and 2008)," exact="Cambodia" post="(2001, 2006, and 2008), Thailand (2001 and 2010), Myanmar"/>
   <result pre="from Vietnam (2007 and 2008), Cambodia (2001, 2006, and 2008)," exact="Thailand" post="(2001 and 2010), Myanmar (2002), Malaysia (2005) and were"/>
   <result pre="2008), Cambodia (2001, 2006, and 2008), Thailand (2001 and 2010)," exact="Myanmar" post="(2002), Malaysia (2005) and were not clustered into the"/>
   <result pre="(2001, 2006, and 2008), Thailand (2001 and 2010), Myanmar (2002)," exact="Malaysia" post="(2005) and were not clustered into the same group"/>
   <result pre="a significant difference as compared with the DENV1 strains in" exact="Singapore" post="(2013), Myanmar (1976), Malaysia (1972), China (2006), Indonesia (1998),"/>
   <result pre="difference as compared with the DENV1 strains in Singapore (2013)," exact="Myanmar" post="(1976), Malaysia (1972), China (2006), Indonesia (1998), and Brunei"/>
   <result pre="compared with the DENV1 strains in Singapore (2013), Myanmar (1976)," exact="Malaysia" post="(1972), China (2006), Indonesia (1998), and Brunei (2006). Fig."/>
   <result pre="the DENV1 strains in Singapore (2013), Myanmar (1976), Malaysia (1972)," exact="China" post="(2006), Indonesia (1998), and Brunei (2006). Fig. 2 Phylogenetic"/>
   <result pre="strains in Singapore (2013), Myanmar (1976), Malaysia (1972), China (2006)," exact="Indonesia" post="(1998), and Brunei (2006). Fig. 2 Phylogenetic tree based"/>
   <result pre="in 2005 and 2008 as well as DENV1 strains in" exact="Thailand" post="in 2010, Myanmar in 2002, Cambodia in 2008, Brunei"/>
   <result pre="2008 as well as DENV1 strains in Thailand in 2010," exact="Myanmar" post="in 2002, Cambodia in 2008, Brunei in 2006, China"/>
   <result pre="as DENV1 strains in Thailand in 2010, Myanmar in 2002," exact="Cambodia" post="in 2008, Brunei in 2006, China in 2017 and"/>
   <result pre="2010, Myanmar in 2002, Cambodia in 2008, Brunei in 2006," exact="China" post="in 2017 and Brazil in 2010 showed differences in"/>
   <result pre="Cambodia in 2008, Brunei in 2006, China in 2017 and" exact="Brazil" post="in 2010 showed differences in many amino acid positions"/>
   <result pre="DENV1 strains and two other DENV type 1 strains from" exact="Cambodia" post="(2006 and 2008). These findings confirmed the origin and"/>
   <result pre="other geographical areas. However, several studies in China, Brunei, and" exact="Singapore" post="have shown DENV1 to be imported from distant geographic"/>
   <result pre="a novel clade of DENV-4 (genotype I) virus in Pune," exact="India" post="during 2016 seasonPLoS One2018132e019267210.1371/journal.pone.019267229470509 6.WadoodAMehmoodAKhanHIlyasMAhmadAAlarjahMet al.Epitopes based drug design"/>
   <result pre="dengue hemorrhagic fever: an analysis of data collected in Bangkok," exact="Thailand" post="from 1994 to 2006PLoS Negl Trop Dis201043e61710.1371/journal.pntd.000061720209155 37.SasmonoRTTaurelAFPrayitnoASitompulHYohanBHayatiRFet al.Dengue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6976675/results/search/country/results.xml">
   <result pre="for the outbreak or epidemic of HFMD in mainland of" exact="China" post="since 201219–21. The change of pathogen spectrum put forward"/>
   <result pre="3 sub-genotypes D1-D3. Most of CV-A6 isolates in mainland of" exact="China" post="belonged to the D2 and D3 sub-genotypes of D"/>
   <result pre="isolated from Henan, Sichuan, Gansu, Shandong and Guangdong provinces of" exact="China" post="in recent years (Fig. 7). Figure 7 Phylogenetic tree"/>
   <result pre="from other international strains were marked with different colors, including" exact="France" post="(red), Spain (green), Finland (wathet), Japan (purple) and Thailand"/>
   <result pre="international strains were marked with different colors, including France (red)," exact="Spain" post="(green), Finland (wathet), Japan (purple) and Thailand (blue). Discussion"/>
   <result pre="were marked with different colors, including France (red), Spain (green)," exact="Finland" post="(wathet), Japan (purple) and Thailand (blue). Discussion HFMD is"/>
   <result pre="with different colors, including France (red), Spain (green), Finland (wathet)," exact="Japan" post="(purple) and Thailand (blue). Discussion HFMD is a worldwide"/>
   <result pre="including France (red), Spain (green), Finland (wathet), Japan (purple) and" exact="Thailand" post="(blue). Discussion HFMD is a worldwide infectious disease, most"/>
   <result pre="strain of EV-A71 virus (genotypes A) was isolated in the" exact="United States" post="in 19691, there has been an epidemic of HFMD"/>
   <result pre="C2 sub-genotypes spread in European and American countries and Australia," exact="Japan" post="from 1970s to 1990s24–26. After 1997, B3~B5 and C3~C6"/>
   <result pre="appear and spread in Southeast Asia13,14,23. EV-A71 virus isolated in" exact="India" post="in 2001 was classified as genotypes D and G,"/>
   <result pre="C4, C5 and B5. B5 and C2 are prevalent in" exact="Malaysia" post="and Singapore23, C2, C4 and B5 are mainly popular"/>
   <result pre="in Vietnam28. C4 sub-genotype was first isolated in mainland of" exact="China" post="in 1998, and this sub-genotype has been prevalent until"/>
   <result pre="same evolutionary origin as that strains epidemic in mainland of" exact="China" post="in recent years. EV-A71 virus has been widely spread"/>
   <result pre="genotype was only the prototype strain and was isolated in" exact="South Africa" post="in 1951. B genotype was divided into two sub-genotypes"/>
   <result pre="alternation of B1a and B1b branches. B1c only occurred in" exact="Malaysia" post="during 2005–2007 and HFMD outbreak in France in 201038."/>
   <result pre="only occurred in Malaysia during 2005–2007 and HFMD outbreak in" exact="France" post="in 201038. The epidemic CV-A16 in mainland of China"/>
   <result pre="in France in 201038. The epidemic CV-A16 in mainland of" exact="China" post="belongs to the B1a and B1b branches of B1,"/>
   <result pre="which is closely related to the strains in Japan, Vietnam," exact="Malaysia" post="and Taiwan, indicating that CV-A16 in China co-evolved with"/>
   <result pre="in Japan, Vietnam, Malaysia and Taiwan, indicating that CV-A16 in" exact="China" post="co-evolved with the strains in the surrounding areas. All"/>
   <result pre="taken place in the worldwide since the first reported in" exact="Finland" post="in 200816, it was circulated in France17, Spain18, and"/>
   <result pre="outbreaks caused by CV-A6 occurred during the same period, including" exact="Singapore" post="in 200914, Japan in 201139, Thailand in 201240, and"/>
   <result pre="CV-A6 occurred during the same period, including Singapore in 200914," exact="Japan" post="in 201139, Thailand in 201240, and mainland of China"/>
   <result pre="the same period, including Singapore in 200914, Japan in 201139," exact="Thailand" post="in 201240, and mainland of China in 201319–21. The"/>
   <result pre="200914, Japan in 201139, Thailand in 201240, and mainland of" exact="China" post="in 201319–21. The phylogenetic tree showed that CV-A6 could"/>
   <result pre="3 sub-genotypes D1-D3. D1 was composed of strains isolated in" exact="Japan" post="in 1999 and in France and Spain from 2008"/>
   <result pre="composed of strains isolated in Japan in 1999 and in" exact="France" post="and Spain from 2008 to 2010, D2 was composed"/>
   <result pre="strains isolated in Japan in 1999 and in France and" exact="Spain" post="from 2008 to 2010, D2 was composed of strains"/>
   <result pre="2008 to 2010, D2 was composed of strains isolated in" exact="Japan" post="and mainland of China from 2008 to 2011, while"/>
   <result pre="was composed of strains isolated in Japan and mainland of" exact="China" post="from 2008 to 2011, while D3 was composed of"/>
   <result pre="composed of strains isolated in Finland, Spain, France, Japan, and" exact="China" post="from 2011 to 2016. Most of the CV-A6 isolates"/>
   <result pre="2011 to 2016. Most of the CV-A6 isolates epidemic in" exact="China" post="after 2012 belonged to the D3 sub-genotype, and clustered"/>
   <result pre="CV-A6 associated HFMD in on the rise in mainland of" exact="China" post="in the same period. In recent years, CV-A6 outbreaks"/>
   <result pre="world. Since the outbreak of HFMD caused by CV-A6 in" exact="Finland" post="in 2008, HFMD with CV-A6 as the main pathogen"/>
   <result pre="From 2009 to 2011, CV-A6 was widely spread in France," exact="Spain" post="and other European countries. And since 2009, CV-A6 has"/>
   <result pre="important pathogens of HFMD in Asian countries, including Singapore, Japan," exact="Thailand" post="and mainland of China. In phylogenetic tree, the epidemic"/>
   <result pre="of China. In phylogenetic tree, the epidemic CV-A6 strains in" exact="China" post="after 2012 were clustered together with the isolates of"/>
   <result pre="were clustered together with the isolates of Japan, Thailand, Finland," exact="Spain" post="and France countries, and the strains were closely related"/>
   <result pre="together with the isolates of Japan, Thailand, Finland, Spain and" exact="France" post="countries, and the strains were closely related to each"/>
   <result pre="control of HFMD issued by the Ministry of health in" exact="China" post="in 2009, the selection criteria for cases in this"/>
   <result pre="supported by the National Science and Technology Major Project of" exact="China" post="(2013ZX10004202) and Science and Technology Project of Shaanxi Province"/>
   <result pre="spectrum of hand, foot, and mouth disease in mainland of" exact="China" post="from 2008 to 2017Biosafety and Health20191324010.1016/j.bsheal.2019.02.005 9.TanXet al.The persistent"/>
   <result pre="al.The largest outbreak of hand; foot and mouth disease in" exact="Singapore" post="in 2008: the role of enterovirus 71 and coxsackievirus"/>
   <result pre="strains isolated from hand, foot, and mouth disease patients in" exact="China" post="revealing frequent recombination of human enterovirus AJ. Clin. Microbiol.201149242610.1128/JCM.00007-1121543560"/>
   <result pre="isolated from hand, foot, and mouth disease patients in Toyama," exact="Japan" post="between 1981 and 2007Jpn. J. Infect. Dis.20096225425919628900 27.BessaudMRet al.Molecular"/>
   <result pre="of Enterovirus 71: predominant recombination C4 viruses persistently circulating in" exact="China" post="for 14 yearsPLoS One20138e5634110.1371/journal.pone.005634123441179 37.ZhangYet al.Molecular evidence of persistent"/>
   <result pre="circulation of Coxsackievirus A6 of genotype D3 in mainland of" exact="China" post="between 2008 and 2015Scientific Reports20177549110.1038/s41598-017-05618-028710474"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC6994851/results/search/country/results.xml">
   <result pre="seasonal influenza and recommended vaccine during the 2016/2017 season in" exact="Nepal" post="JhaBimalesh KumarabPanditRoshanroshanpandit2050@gmail.coma∗JhaRunaaManandharKrishna Dasb[a], [b], ∗Corresponding author. roshanpandit2050@gmail.com pmc-release: 2020-1-1collection:"/>
   <result pre="aimed to investigate the types of influenza viruses prevailing in" exact="Nepal" post="during 2016 and, to match the recommended vaccine for"/>
   <result pre="study was carried out at National Public Health Laboratory, Kathmandu," exact="Nepal" post="for the period of one year (Jan–Dec 2016). A"/>
   <result pre="of B/Yamagata lineage over B/Victoria lineage. Conclusion We concluded that" exact="Nepal" post="experiences semiannual cycle of influenza infection, firstly during the"/>
   <result pre="the month of July–August. The vaccine to be introduced in" exact="Nepal" post="need to be decided by national authority based on"/>
   <result pre="Virus, Vaccine. Keywords Microbiology Genetics Molecular biology Health sciences Influenza" exact="Nepal" post="Prevalence Virus Vaccine 1 Introduction Influenza is a highly"/>
   <result pre="Asian flu in 1957 caused by H2N2 and the third" exact="Hong Kong" post="flu in 1968 by H3N2 [9]. Studies suggest that"/>
   <result pre="the spread of viruses. The first outbreak of influenza in" exact="Nepal" post="was detected in year 2004 at Bhutanese refugee camp"/>
   <result pre="which was caused by influenza A/H3 serotype [12]. Since then," exact="Nepal" post="has an increasing number of influenza positive cases with"/>
   <result pre="1. to determine the seasonal activity of influenza virus in" exact="Nepal" post="in year 2016 and, 2. to check whether the"/>
   <result pre="was carried out at National Public Health Laboratory (NPHL), Kathmandu," exact="Nepal" post="for the period of one year (January–December 2016). Altogether"/>
   <result pre="Ethical approval was obtained from National Public Health Laboratory and" exact="Nepal" post="Health Research Council (NHRC ref. no. 1673) before carrying"/>
   <result pre="Laboratory being only one diagnosis center for influenza infection in" exact="Nepal" post="during 2016, patients from all over Nepal were referred"/>
   <result pre="influenza infection in Nepal during 2016, patients from all over" exact="Nepal" post="were referred to NPHL. We recorded total patients from"/>
   <result pre="higher number of cases (Figure 2). Figure 2 Map of" exact="Nepal" post="showing districts with influenza cases in year 2016. 3.2"/>
   <result pre="suggest that influenza A/H3 was the predominant strain circulating in" exact="Nepal" post="in year 2016. A previous study by Upadhyay et"/>
   <result pre="for 60.1% of the total infection in year 2014 in" exact="Nepal" post="[14]. A study from countries in tropical Asia also"/>
   <result pre="of influenza virus in different study. This study illustrates that" exact="Nepal" post="observes two peaks of influenza infection round the year;"/>
   <result pre="rainy season. This is further supported by a study from" exact="India" post="which reports maximum influenza activity during the rainy season"/>
   <result pre="A study carried out by Sun et al. from mainland" exact="China" post="also reported two peak of influenza activity; first in"/>
   <result pre="influenza activity in winter season [26]. Similarly, a study from" exact="Hong Kong" post="also reports annual cycle of influenza A(H3N2) during the"/>
   <result pre="higher prevalence of influenza in comparison to other districts of" exact="Nepal" post="[28, 29]. Also, Kathmandu valley and nearby districts are"/>
   <result pre="did not find any guidelines made by national authorities in" exact="Nepal" post="regarding influenza vaccine use. However, clinician preferred to use"/>
   <result pre="preferred to use trivalent vaccine and, was widely available in" exact="Nepal" post="during the season. The trivalent vaccine consisted of: A/California/7/2009"/>
   <result pre="lineage viruses. But, since we found B/Yamagata lineage dominant in" exact="Nepal" post="over B/Victoria lineage in year 2016, we noticed a"/>
   <result pre="[21]. For this reason the vaccine to be introduced in" exact="Nepal" post="should be decided by national authority in Nepal based"/>
   <result pre="introduced in Nepal should be decided by national authority in" exact="Nepal" post="based on prevailing strain to confer effective immunization. Furthermore,"/>
   <result pre="Conclusion and recommendations This study set out to determine that" exact="Nepal" post="experience semiannual cycle of influenza infection firstly, during the"/>
   <result pre="This paper argued that the vaccine to be introduced in" exact="Nepal" post="must be decided by national authority based on prevailing"/>
   <result pre="timing and composition of influenza vaccine to be introduced in" exact="Nepal" post="by the national authority to confer effective immunization and"/>
   <result pre="paper. References References 1KorsunN.AngelovaS.TrifonovaI.GeorgievaI.TzotchevaI.MilevaS.Predominance of influenza B/Yamagata lineage viruses in" exact="Bulgaria" post="during the 2017/2018 seasonEpidemiol. Infect.2019147 2Centers for Disease Control"/>
   <result pre="swine influenza A/H1N1 and the phase six pandemicJNMA - J." exact="Nepal" post="Med. Assoc.49179201025525822049835 6TaubenbergerJ.K.MorensD.M.Influenza: the once and future pandemicPubl. Health"/>
   <result pre="outbreak, NepalEmerg. Infect. Dis.1182005118616102305 13KandelN.ShresthaJ.M.UpadhyayB.ShresthaA.ShakyaG.Pandemic (H1N1) 2009 cases in NepalJ." exact="Nepal" post="Med. Assoc. JNMA521882012 14UpadhyayB.P.GhimireP.TashiroM.BanjaraM.R.Molecular epidemiology and antigenic characterization of"/>
   <result pre="and antigenic characterization of seasonal influenza viruses circulating in NepalJ." exact="Nepal" post="Health Res. Counc.1512017445028714491 15NeopaneA.The swine flu pandemic in NepalKathmandu"/>
   <result pre="J.742009339340 16MahatoR.BhandariG.ShresthaJ.BasnetP.Pandemic influenza A (H1N1) 2009 outbreak investigation in NepalJ." exact="Nepal" post="Health Res. Counc.2011 17FitznerJ.QasmiehS.MountsA.W.AlexanderB.BesselaarT.BriandS.Revision of clinical case definitions: influenza-like"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7018131/results/search/country/results.xml">
   <result pre=": People and places : Geographical locations : South America:" exact="Brazil" post=": Medicine and Health Sciences : Infectious Diseases: Infectious"/>
   <result pre="distribution of dengue in Brazil, 1990 - 2017 Dengue in" exact="Brazil" post="AndrioliDenise CatarinaConceptualizationData curationFormal analysisInvestigationMethodologySupervisionValidationVisualizationWriting – original draftWriting – review"/>
   <result pre="Community University of the Region of Chapecó, Chapecó, Santa Catarina," exact="Brazil" post="* E-mail: assunta@unochapeco.edu.br epub: 2020-2-2collection: 2020152e0228346received: 2020-1-11accepted: 2020-1-13(C) Andrioli"/>
   <result pre="caused by an arbovirus of the genus Flavivirus transmitted in" exact="Brazil" post="by the mosquito Aedes aegypti (Linnaeus, 1762). Simultaneous circulation"/>
   <result pre="study aimed to describe the epidemiological situation of dengue in" exact="Brazil" post="in the last three decades. This is a descriptive,"/>
   <result pre="http://portalms.saude.gov.br/boletins-epidemiologicos. The relevant files report on cases of dengue in" exact="Brazil" post="from 2003-2018. The authors did not have special access"/>
   <result pre="Aedes aegypti being the urban vector responsible for transmission in" exact="Brazil" post="[5]. The infection may be asymptomatic or symptomatic. When"/>
   <result pre="and DENV4. In recent years, dengue has been spread in" exact="Brazil" post="[6]. Several studies have demonstrated the economic and social"/>
   <result pre="study aimed to describe the epidemiological situation of dengue in" exact="Brazil" post="in the last three decades. Method Context The study"/>
   <result pre="last decade (2008 to 2017). The largest epidemics faced by" exact="Brazil" post="were recorded in 2015 (1,688,688 cases), with an incidence"/>
   <result pre="the annual and regional variation of annual dengue notifications in" exact="Brazil" post="were explained by PCA. The Center-West and Northeast regions"/>
   <result pre="has become one of the greatest public health challenges in" exact="Brazil" post="in the last two decades. The epidemiology of the"/>
   <result pre="2016, with the highest absolute number of new cases in" exact="Brazil" post="[27]. DALY increased more than double in all Brazilian"/>
   <result pre="São Paulo, the latter being the most populous state in" exact="Brazil" post="[21]. However, the highest rate (444.8 cases/100 thousand inhabitants)"/>
   <result pre="there was a predominance of the DENV-2 serotype, introduced in" exact="Brazil" post="in 1990, when the first cases of Dengue Hemorrhagic"/>
   <result pre="vector-borne diseases. Our results suggest that the northern area of" exact="Brazil" post="(approximately equivalent to the Amazon region) is more likely"/>
   <result pre="Salinas-EscuderoG, Ramírez-ChávezA, CastañedaJR, Hernández-GaytánSI, et al.Economic impact of dengue in" exact="Mexico" post="considering reported cases for 2012 to 2016. PLoS Negl"/>
   <result pre="SiqueiraJBJr, FerreiraGLC, BricksL, JointG. Epidemiological Trends of Dengue Disease in" exact="Brazil" post="(2000–2010): A Systematic Literature Search and Analysis. PLoS Negl"/>
   <result pre="AmâncioFF, PassosVMDA, CarneiroM. Increase in the burden of dengue in" exact="Brazil" post="and federated units, 2000 and 2015: analysis of the"/>
   <result pre="Local and global effects of climate on dengue transmission in" exact="Puerto Rico." post="PLoS Negl Trop Dis2009; 3(2):e382 Epub 2009/02/18. 10.1371/journal.pntd.000038219221592 31DesclouxE,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7019949/results/search/country/results.xml">
   <result pre="of measles in developed countries, including the Americas, Europe, and" exact="Australia" post="found that 100% of measles cases were imported or"/>
   <result pre="with movement of individuals between rural and urban areas in" exact="Sierra Leone," post="Guinea, and Liberia [14]. This led the international community"/>
   <result pre="between rural and urban areas in Sierra Leone, Guinea, and" exact="Liberia" post="[14]. This led the international community to restrict air"/>
   <result pre="rate of infectious diseases among different populations [23,24]. In the" exact="United States," post="efforts focused on prevention of disease transmission and dissemination"/>
   <result pre="found that viral introductions into KwaZulu-Natal, a rural region in" exact="South Africa," post="were a major driver of the ongoing epidemic, accounting"/>
   <result pre="HIV epidemics. Expanding to international travel, a study conducted in" exact="France" post="assessed the frequency of travel-related illnesses among residents of"/>
   <result pre="France assessed the frequency of travel-related illnesses among residents of" exact="France" post="who had returned from abroad with an infectious disease"/>
   <result pre="associated with international travel in the region of the Americas," exact="Australia" post="and Europe, 2001–2013: A systematic reviewTravel Med. Infect. Dis.201513101810.1016/j.tmaid.2014.10.02225468523"/>
   <result pre="al.A national study of the molecular epidemiology of HIV-1 in" exact="Australia" post="2005–2012PLoS ONE201712e017060110.1371/journal.pone.017060128489920 31.ChaillonA.Avila-RiosS.WertheimJ.O.DennisA.Garcia-MoralesC.Tapia-TrejoD.Mejia-VillatoroC.PascaleJ.M.Porras-CortesG.Quant-DuranC.J.et al.Identification of major routes of HIV"/>
   <result pre="Dynamics of a Novel HIV-1 Subtype G Clade Circulating in" exact="Cape Verde" post="and PortugalPLoS ONE201510e012738410.1371/journal.pone.012738425993094 33.LeroyH.ArvieuxC.BiziragusenyukaJ.ChapplainJ.M.GuiguenC.MicheletC.TattevinP.A retrospective study of 230 consecutive"/>
   <result pre="Dis.2015611462146810.1093/cid/civ52626129754 47.WangY.LiangY.FengY.WangB.LiY.WuZ.ZhangJ.BalochZ.ZhangA.M.LiuL.et al.HIV-1 prevalence and subtype/recombinant distribution among travelers entering" exact="China" post="from Vietnam at the HeKou port in the Yunnan"/>
   <result pre="(2017) [30] Determine HIV-1 subtype distribution and phylogenetic structure in" exact="Australia" post="between 2005 and 2012 HIV-1 epidemic in Australia is"/>
   <result pre="structure in Australia between 2005 and 2012 HIV-1 epidemic in" exact="Australia" post="is characterized by an increasing prevalence of non-B subtype"/>
   <result pre="various Mesoamerican countries, but analyses indicate that Central and Southern" exact="Mexico" post="and Belize were significant sources of HIV transmission throughout"/>
   <result pre="countries, but analyses indicate that Central and Southern Mexico and" exact="Belize" post="were significant sources of HIV transmission throughout MesoamericaEvidence of"/>
   <result pre="of HIV transmission throughout MesoamericaEvidence of significant viral migration within" exact="Mexico" post="Human migration or travel is assumed to be the"/>
   <result pre="routes of the HIV-1 subtype G clades present throughout Angola," exact="Cape Verde," post="and Portugal HIV-1 subtype G likely originated in Central"/>
   <result pre="HIV-1 subtype G clades present throughout Angola, Cape Verde, and" exact="Portugal" post="HIV-1 subtype G likely originated in Central Africa and"/>
   <result pre="later The local dissemination of HIV-1 subtype G infections in" exact="Cape Verde" post="and Portugal are shaped by historical and ongoing movement"/>
   <result pre="dissemination of HIV-1 subtype G infections in Cape Verde and" exact="Portugal" post="are shaped by historical and ongoing movement of human"/>
   <result pre="by historical and ongoing movement of human populations between Angola," exact="Cape Verde," post="and Portugal Leroy (2008) [33] To assess the frequency"/>
   <result pre="ongoing movement of human populations between Angola, Cape Verde, and" exact="Portugal" post="Leroy (2008) [33] To assess the frequency of travel-related"/>
   <result pre="illnesses among ill-returned travelers in one infectious diseases department in" exact="France" post="Of the 265 diagnoses made in travelers who returned"/>
   <result pre="sequence variability among travel-associated cases with reported infection outside of" exact="Poland" post="and trace the country of origin where infected was"/>
   <result pre="they traveled to Results show genetic variations in HIV within" exact="Lebanon" post="and the discovery of new HIV-subtypes which indicate extreme"/>
   <result pre="new HIV-subtypes which indicate extreme heterogeneity of HIV subtypes in" exact="Lebanon" post="Rasmussen (2018) [40] Quantify the contribution of local viral"/>
   <result pre="infection acquired in Africa and among African communities in the" exact="United Kingdom" post="African-acquired HIV infections diagnosed in the United Kingdom by"/>
   <result pre="in the United Kingdom African-acquired HIV infections diagnosed in the" exact="United Kingdom" post="by 2001 make up about 21% of all reported"/>
   <result pre="the possibility of locating evidence for ongoing non-B transmission in" exact="Switzerland" post="by identifying possible transmission pairs Migration has a greater"/>
   <result pre="non-B subtype HIV-1A fraction of all non-B infections diagnosed in" exact="Switzerland" post="could be prevented by local interventionsTo contain HIV dissemination,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7038879/results/search/country/results.xml">
   <result pre="Women's HospitalBostonMAUSA[3], Harvard School T.H. Chan School of Public HealthBostonMAUSA[4]," exact="Botswana" post="Harvard AIDS Institute PartnershipGaboroneBotswana[5], Clinical Research DepartmentLondon School of"/>
   <result pre="Discussion These three‐year studies were conducted in Botswana, Zambia, Uganda," exact="Kenya" post="and South Africa in settings with baseline HIV prevalence"/>
   <result pre="three‐year studies were conducted in Botswana, Zambia, Uganda, Kenya and" exact="South Africa" post="in settings with baseline HIV prevalence from 4% to"/>
   <result pre="a variety of conditions of HIV testing and treatment using" exact="South Africa" post="epidemiological and demographic parameters 4. Their model predicted that"/>
   <result pre="2 Discussion UTT consortium investigators independently conducted four studies in" exact="South Africa," post="Zambia, Uganda and Kenya in populations with HIV prevalence"/>
   <result pre="consortium investigators independently conducted four studies in South Africa, Zambia," exact="Uganda" post="and Kenya in populations with HIV prevalence among adults"/>
   <result pre="independently conducted four studies in South Africa, Zambia, Uganda and" exact="Kenya" post="in populations with HIV prevalence among adults ranging from"/>
   <result pre="BCPP/Ya Tsie HPTN 071 (PopART) SEARCH ANRS 12249 (TasP) Country" exact="Botswana" post="South Africa/Zambia Kenya/Uganda South Africa Prevalence 29% 22% 4%"/>
   <result pre="(PopART) SEARCH ANRS 12249 (TasP) Country Botswana South Africa/Zambia Kenya/Uganda" exact="South Africa" post="Prevalence 29% 22% 4% to 19% 30% Arm C"/>
   <result pre="in the control arms in all studies but TasP, as" exact="South Africa" post="guidelines did not change until the very end of"/>
   <result pre="and far exceed those of developed countries such as the" exact="United States," post="where population‐level viral suppression was recently reported as 51%"/>
   <result pre="have also notably reached the UNAIDS 73% target: Eswatini 73%;" exact="Namibia" post="77% and Rwanda 76% 25. 2.5 HIV incidence and"/>
   <result pre="reached the UNAIDS 73% target: Eswatini 73%; Namibia 77% and" exact="Rwanda" post="76% 25. 2.5 HIV incidence and mortality In BCPP"/>
   <result pre="challenges within the ANRS 12249 TasP cluster‐randomized trial in rural" exact="South Africa." post="J Int AIDS Soc. 2016;19(1):20913.27258430 20SeeleyJ, BondV, YangB, FloydS,"/>
   <result pre="start ART in seven HPTN 071 (PopART) study communities in" exact="Zambia" post="and South Africa. AIDS Behav. 2019;23(4):929–46.30415432 21CurranK, NgureK, Shell‐DuncanB,"/>
   <result pre="in seven HPTN 071 (PopART) study communities in Zambia and" exact="South Africa." post="AIDS Behav. 2019;23(4):929–46.30415432 21CurranK, NgureK, Shell‐DuncanB, VushaS, MugoNR, HeffronR,"/>
   <result pre="care among HIV‐infected men in a universal test‐and‐treat setting in" exact="Uganda" post="and Kenya: A mixed methods analysis. PLoS ONE. 2019;14:e0210126.30673744"/>
   <result pre="al. Access to HIV care and treatment for migrants between" exact="Lesotho" post="and South Africa: a mixed methods study. BMC Public"/>
   <result pre="HPTN 071 (PopART) Study. IAS 2019 Conference; 2019 July 21‐24;" exact="Mexico" post="City, Mexico: International AIDS Society; 2019. 29KamyaM, PetersenML, KwariisimaD,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7076175/results/search/country/results.xml">
   <result pre="of Agriculture and Rural Affairs, and College of Veterinary Medicine," exact="China" post="Agricultural UniversityBeijingChina Edited by: Chunfu Zheng, Fujian Medical University,"/>
   <result pre="China Agricultural UniversityBeijingChina Edited by: Chunfu Zheng, Fujian Medical University," exact="China" post="Reviewed by: Tong-Qing An, Harbin Veterinary Research Institute (CAAS),"/>
   <result pre="Veterinary Research Institute (CAAS), China; Hongjie Fan, Nanjing Agricultural University," exact="China" post="*Correspondence: Jun Han, hanx0158@cau.edu.cn Hanchun Yang, yanghanchun1@cau.edu.cn This article"/>
   <result pre="successfully eradicated from domestic pigs of many countries, including the" exact="United States," post="most of Europe and New Zealand (Pannett et al.,"/>
   <result pre="many countries, including the United States, most of Europe and" exact="New Zealand" post="(Pannett et al., 1999; An et al., 2013; Ketusing"/>
   <result pre="al., 2013; Sun et al., 2016); it was imported from" exact="Hungary" post="in 1979 that contains a complete deletion of the"/>
   <result pre="of PR emerged suddenly in Bartha-K61-vaccinated swine farms in North" exact="China" post="and then quickly spread to most parts of the"/>
   <result pre="PR outbreak of a swine farm in Hebei province of" exact="China" post="in 2012. PRV Bartha-K61 vaccine strain (Genbank no. JF797217.1)"/>
   <result pre="study were approved by the Laboratory Animal Ethical Committee of" exact="China" post="Agricultural University with the license number (CAU20180823-1). All 4-week-old"/>
   <result pre="reviewed and approved by the Laboratory Animal Ethical Committee of" exact="China" post="Agricultural University. Author Contributions JH and HY conceptualized the"/>
   <result pre="of the Ministry of Science and Technology of China, the" exact="China" post="National Thousand Youth Talents program (1051-21986001), and the earmarked"/>
   <result pre="Thousand Youth Talents program (1051-21986001), and the earmarked fund for" exact="China" post="Agriculture Research System from the Ministry of Agriculture of"/>
   <result pre="China Agriculture Research System from the Ministry of Agriculture of" exact="China" post="(CARS-35). The funders had no role in study design,"/>
   <result pre="PannettG. R.MothaM. X.MacdiarmidS. C. (1999). Eradication of Aujeszky’s disease from" exact="New Zealand" post="pig herds 1976-1997.Vet. Rec.144365–369. 10.1136/vr.144.14.36510327536 PomeranzL. E.ReynoldsA. E.HengartnerC. J."/>
   <result pre="Z.ChenH. C. (1999). Pseudorabies epidemic status and control measures in" exact="China" post="[in Chinese].Chin. J. Vet. Sci.191–2. 10.16303/j.cnki.1005-4545.1999.01.001 TongW.LiG.LiangC.LiuF.TianQ.CaoY.et al. (2016)."/>
   <result pre="reveal that partial sequence of an earlier pseudorabies virus in" exact="China" post="is originated from a Bartha-vaccine-like strain.Virology49156–63. 10.1016/j.virol.2016.01.01626874017 YeC.ZhangQ. Z.TianZ."/>
   <result pre="J.ZhengH.ZhaoK.LiuF.et al. (2015). Genomic characterization of emergent pseudorabies virus in" exact="China" post="reveals marked sequence divergence: evidence for the existence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7077840/results/search/country/results.xml">
   <result pre="Public Service &amp;amp; Community Solutions, Arizona State University, Phoenix, AZ," exact="United States" post="of AmericaForgostonEricEditor[], Montclair State University, UNITED STATES Competing Interests:"/>
   <result pre="2014, an Ebola epidemic impacted West Africa, most notably Liberia," exact="Guinea" post="and Sierra Leone. We demonstrate the value of social"/>
   <result pre="Ebola epidemic impacted West Africa, most notably Liberia, Guinea and" exact="Sierra Leone." post="We demonstrate the value of social media for automated"/>
   <result pre="index case for the epidemic was a 2-year-old boy in" exact="Guinea" post="who died on December 6, 2013. The Guinean Ministry"/>
   <result pre="of dissemination Meliandou Health Post January 24, 2014 Internal alert" exact="Guinea" post="Ministry of Health March 13, 2014 Internal alert HealthMap"/>
   <result pre="The highest RSVs were from the three main affected countries." exact="Liberia" post="had the highest score, followed by Sierra Leone and"/>
   <result pre="main affected countries. Liberia had the highest score, followed by" exact="Sierra Leone" post="and Guinea. However, the most searches for the keyword"/>
   <result pre="Locations: We search for locations in key locations in Liberia," exact="Guinea" post="and Sierra Leone. The details are provided in the"/>
   <result pre="search for locations in key locations in Liberia, Guinea and" exact="Sierra Leone." post="The details are provided in the Appendix. TPSA searches"/>
   <result pre="location of our dataset. This is expected since, among Guinea," exact="Sierra Leone" post="and Liberia, Liberia had the highest access to the"/>
   <result pre="This is expected since, among Guinea, Sierra Leone and Liberia," exact="Liberia" post="had the highest access to the Internet (16.5%, as"/>
   <result pre="66% [16]. Only 1.6% of people in Guinea, 1.7% in" exact="Sierra Leone" post="and 16.5% in Liberia had access to the Internet"/>
   <result pre="people in Guinea, 1.7% in Sierra Leone and 16.5% in" exact="Liberia" post="had access to the Internet during the outbreak[10]. Hence,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7080275/results/search/country/results.xml">
   <result pre="Islands : People and places : Geographical locations : Oceania:" exact="French Polynesia" post=": Medicine and Health Sciences : Epidemiology: Spatial Epidemiology"/>
   <result pre="persistence of monotypic dengue transmission in small size isolated populations," exact="French Polynesia," post="1978-2014 Persistent dengue in small islands TeissierYoannData curationInvestigationResourcesWriting –"/>
   <result pre="France[9], iGLOBE, UMI CNRS 3157, University of Arizona, Tucson, Arizona," exact="United States" post="of America[10], IBENS, UMR 8197 CNRS-ENS Ecole Normale Supérieure,"/>
   <result pre="regions where serotypes co-circulate and there is extensive human mobility." exact="French Polynesia," post="an isolated group of 117 islands of which 72"/>
   <result pre="and low population size, dengue cases were observed somewhere in" exact="French Polynesia" post="almost constantly, in part due to the spatial structuration"/>
   <result pre="complexified by the occurrence of several co-circulating serotypes. By contrast," exact="French Polynesia," post="an isolated group of 72 inhabited islands in the"/>
   <result pre="and analyzing a database of laboratory-confirmed dengue cases from across" exact="French Polynesia" post="over a 35 year period we were able to"/>
   <result pre="sea links. This remarkable long-term persistence of dengue virus in" exact="French Polynesia" post="could be maintained by asynchronous viral transmission among connected"/>
   <result pre="is challenging [6–9]. In contrast to such mainland hyperendemic settings," exact="French Polynesia" post="has a small population size (275 918 inhabitants, 2017"/>
   <result pre="climate permissive for perennial mosquito-borne virus transmission [10]. Since 1944," exact="French Polynesia" post="Public Health authorities have reported 14 monotypic dengue epidemics"/>
   <result pre="description of the data is the question as to whether" exact="French Polynesia" post="is effectively a meta-population whereby DENV is maintained by"/>
   <result pre="the first collation, description and analysis of dengue dynamics in" exact="French Polynesia" post="over a 35-year period, from 1978 to 2014. Methods"/>
   <result pre="1978 to 2014. Methods Study site, demographic and migration data" exact="French Polynesia" post="is located in the middle of the Pacific ocean"/>
   <result pre="the correlation with the cross-correlation function. Fig 1 Map of" exact="French Polynesia" post="showing the five administrative subdivisions and associated islands. [12]."/>
   <result pre="has been involved in arbovirus diagnostic, surveillance and research in" exact="French Polynesia" post="since the 1960s. The ILM receives samples from medical"/>
   <result pre="samples from medical practitioners, health centers and laboratories all over" exact="French Polynesia" post="and has recorded dengue confirmed cases from March 1975."/>
   <result pre="Genstat version 15 [13]. Wavelet analyses As dengue dynamics in" exact="French Polynesia" post="are very non-stationary, wavelet analyses were performed to explore"/>
   <result pre="S1 Fig). Fig 2 Incidence of confirmed dengue cases in" exact="French Polynesia" post="from August 1978 until October 2014. Total number of"/>
   <result pre="Total number of dengue cases per month per subdivision of" exact="French Polynesia." post="A- Windward Islands, B. Leeward Islands, C. Marquesas Islands,"/>
   <result pre="of reported dengue cases for more than 1 month throughout" exact="French Polynesia" post="was recorded on only 16 occasions (range 2–9 months),"/>
   <result pre="cases were observed at least every other month somewhere across" exact="French Polynesia." post="To assess the Critical community size (CCS) permitting continuous"/>
   <result pre="series data from 12 of the most populated islands of" exact="French Polynesia" post="are displayed in S6 and S7 Figs. These 12"/>
   <result pre="periods. With exception of Tahiti, the most populated island of" exact="French Polynesia," post="viral die-out at an island level was frequent and"/>
   <result pre="almost permanent circulation of virus was observed for decades across" exact="French Polynesia" post="and the estimated CCS of 175 000 was only"/>
   <result pre="a metapopulation approach to understanding the dynamics of dengue in" exact="French Polynesia" post="is useful, based on classical concepts of synchrony and"/>
   <result pre="These observations would support a meta-population structure to transmission within" exact="French Polynesia," post="where the virus hops from island to island, especially"/>
   <result pre="source of transmission [8]. More generally across the entirety of" exact="French Polynesia," post="three of the eight epidemics fizzled out after a"/>
   <result pre="a feature of the South Pacific region [23–26], except for" exact="French Polynesia." post="Epidemic recrudescence of a persisting DENV occurred in 2006,"/>
   <result pre="Marquesas that had been spared the 2001 epidemic. How in" exact="French Polynesia," post="whatever the serotype, DENV circulation can persist between epidemics"/>
   <result pre="study was the association of dengue incidence with climate. In" exact="French Polynesia," post="climate is suitable for dengue transmission year round with"/>
   <result pre="This seems likely to be occurring to some extent in" exact="French Polynesia," post="but limited to the most inhabited islands. Inter-connectedness of"/>
   <result pre="and the sum of the monthly dengue cases across all" exact="French Polynesia." post="Shown is the best fit line from the GLM"/>
   <result pre="from the first 6 of the 12 major islands of" exact="French Polynesia." post="Left panel: Local wavelet power spectrum. Colours code for"/>
   <result pre="from the second 6 of the 12 major islands of" exact="French Polynesia." post="Left panel: Local wavelet power spectrum. Colours code for"/>
   <result pre="dengue virus transmission across interepidemic and epidemic periods in Iquitos," exact="Peru" post="(1999–2003). PLoS Negl Trop Dis2012; 6(2): e147210.1371/journal.pntd.000147222363822 7SaljeH, LesslerJ,"/>
   <result pre="2018]. http://www.ispf.pf/bases/Recensements/2017/poplegale.aspx. 11AubryM, Cao-LormeauVM. History of arthropod-borne virus infections in" exact="French Polynesia." post="New Microbes New Infect. 201928;29:10051310.1016/j.nmni.2019.01.00930899520 12AubryM, TeissierA, HuartM, MerceronS,"/>
   <result pre="12AubryM, TeissierA, HuartM, MerceronS, VanhomwegenJ, RocheC, et al.Zika Virus Seroprevalence," exact="French Polynesia," post="2014–2015. Emerg Infect Dis. 20174;23(4):669–672. 10.3201/eid2304.16154928084987 13GenStat for Windows"/>
   <result pre="PongsiriA, ThaisomboonsukB, KlungthongC, RichardsonJH, et al.Dengue-1 virus clade replacement in" exact="Thailand" post="associated with enhanced mosquito transmission. J Virol2012; 86(3): 1853–1861."/>
   <result pre="DaudensE, et al.Recent Emergence of Dengue Virus Serotype 4 in" exact="French Polynesia" post="Results from Multiple Introductions from Other South Pacific Islands."/>
   <result pre="27DesclouxE, Cao-LormeauVM, RocheC, De LamballerieX. Dengue 1 diversity and microevolution," exact="French Polynesia" post="2001–2006: connection with epidemiology and clinics. PLoS Negl Trop"/>
   <result pre="MapotoekeM, Mariteragi-HelleT, et al.Seroprevalence of Dengue and Chikungunya Virus Antibodies," exact="French Polynesia," post="2014–2015. Emerg Infect Dis2018; 24(3): 558–561. 10.3201/eid2403.17114929460745 31JachowskiL.A. Filariasis"/>
   <result pre="2014–2015. Emerg Infect Dis2018; 24(3): 558–561. 10.3201/eid2403.17114929460745 31JachowskiL.A. Filariasis in" exact="American Samoa." post="V. Bionomics of the principal vector, Aedes polynesiensis Marks."/>
   <result pre="60: 186–203. .13197370 32RichardV, Cao-LormeauVM. Mosquito vectors of arboviruses in" exact="French Polynesia." post="New Microbes New Infect. 2019610; 31:10056910.1016/j.nmni.2019.10056931316821 33MammenMP, PimgateC, KoenraadtCJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7082452/results/search/country/results.xml">
   <result pre="Complete Genome Analysis of Influenza A(H1N1) Viruses Isolated in Kerala," exact="India" post="Microbiology Resource Announcement Prasad et al. PrasadRajiaMohanakumariVishnu VikramanThampiaSasiRemya VasanthiaNairRadhakrishnanbJonesSaraaPillaiMadhavan"/>
   <result pre="and Molecular Diagnostic, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala," exact="India" post="DennehyJohn J.Editor[], Address correspondence to Sara Jones, sara@rgcb.res.in. Citation"/>
   <result pre="concern throughout the world. During the first half of 2017," exact="India" post="saw an increase in morbidity and mortality rates caused"/>
   <result pre="AnukumarB, LalRB, MishraAC2015Dynamics of influenza seasonality at sub-regional levels in" exact="India" post="and implications for vaccination timing. PLoS One10:e0124122. doi:10.1371/journal.pone.0124122.25938466 5.KulkarniSV,"/>
   <result pre="functional implications for the influenza A (H1N1) infection outbreak in" exact="India" post="from 2009 to 2017. Sci Rep9:14690. doi:10.1038/s41598-019-51097-w.31604969 8.PotdarVA, ChadhaMS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7086318/results/search/country/results.xml">
   <result pre="with human parechovirus type 3 (HPeV3) was reported in Yamagata," exact="Japan" post="(4). Subsequently, HPeV3-associated myalgia was reported in Osaka City"/>
   <result pre="one-year-old child with transient paralysis, a fever, and diarrhea in" exact="Japan" post="(9). HPeV infections, such as those associated with HPeV1,"/>
   <result pre="it was once referred to as an &quot;unusual outbreak&quot; in" exact="Japan" post="(8). This might be, at least in part, because"/>
   <result pre="suggests that HPeV3 infection was prevalent in several areas of" exact="Japan" post="in 2016. Reported cases of epidemic myalgia associated with"/>
   <result pre="center, HPeV3 epidemics occur every two to three years in" exact="Japan" post="(14). Interestingly, the HPeV3 epidemics appear to be closely"/>
   <result pre="the prevalence of HPeV3-associated epidemic myalgia in various areas of" exact="Japan" post="is important for improving the public health response during"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7093347/results/search/country/results.xml">
   <result pre="Professor Fangzhou Gu learned from the academic conference that the" exact="United States" post="and the Soviet Union are cooperating to develop a"/>
   <result pre="proposal was decisive meaningful for the elimination of polio in" exact="China" post="eventually, which also becomes the greatest contribution made by"/>
   <result pre="in his life. Therefore, Professor Fangzhou Gu immediately returned to" exact="China" post="and started the development of a live vaccine for"/>
   <result pre="II and III attenuated vaccines for 5 million people in" exact="China" post="(Gu et al. 1961). At this time, three phases"/>
   <result pre="of polio. In 2000, the World Health Organization confirmed that" exact="China" post="had successfully blocked the spread of native wild poliovirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7098094/results/search/country/results.xml">
   <result pre="otherwise stated in a credit line to the data. Abstract" exact="Mozambique" post="has one of the highest burdens of HIV globally,"/>
   <result pre="vulnerable population. Keywords Harm reduction Youth People who inject drugs" exact="Mozambique" post="Background The period of adolescence and youth aged 10–24 years"/>
   <result pre="(BBS) survey conducted in 2013–2014 in two urban areas in" exact="Mozambique" post="revealed a high prevalence of HIV estimated to be"/>
   <result pre="this high burden of disease, PWID were recognized by the" exact="Mozambique" post="National Strategic HIV/AIDS Response Plan (2015–2019) as a high-risk"/>
   <result pre="disease among this age-group [1, 3, 17]. Young PWID in" exact="Mozambique" post="Young people, who make up 32.5% of the Mozambican"/>
   <result pre="heightened among young PWID. Data from the first BBS in" exact="Mozambique" post="show that HIV prevalence among PWID aged 18–24 in"/>
   <result pre="HIV or drugs [6]. Substance abuse services for PWID in" exact="Mozambique" post="are integrated into programs managed by the National Mental"/>
   <result pre="During qualitative interviews conducted as part of the BSS, PWID" exact="Mozambique" post="listed the co-location of substance abuse services within mental"/>
   <result pre="National Harm Reduction Plan: recommendations It is imperative that the" exact="Mozambique" post="Mental Health Program incorporate the specific needs of youth"/>
   <result pre="the National Harm Reduction Plan is an opportune time for" exact="Mozambique" post="to consider comprehensive and integrated harm reduction programs and"/>
   <result pre="the provision of a youth-friendly health services programme in rural" exact="South Africa." post="BMC Health Serv Res. 2014;14:259. 6.WHO. A techincal brief."/>
   <result pre="https://dhsprogram.com/pubs/pdf/AIS12/AIS12.pdf. Accessed 28 Feb 2020. 20.MISAU INS. Final report: the" exact="Mozambique" post="Integrated Biological and Behavioral Survey among people who inject"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7098263/results/search/country/results.xml">
   <result pre="HIV-1 groups N, O and P remained mostly confined to" exact="Cameroon" post="and neighboring countries, the group M spread out of"/>
   <result pre="HIV-1 group M in humans was first detected in the" exact="United States" post="of America and Europe in the early 1980s, shortly"/>
   <result pre="HIV-1 group was already present in the Democratic Republic of" exact="Congo" post="(DRC) by the late 1950s, tracing the most recent"/>
   <result pre="revealed that most HIV-1 pandemic lineages first spread from the" exact="Congo" post="basin to neighboring regions in southern, eastern, and west"/>
   <result pre="exportation of a subtype A lineage from the DRC to" exact="Ukraine" post="in the 1980s, where it initially spread via heterosexual"/>
   <result pre="BCAR epidemic resulted from early viral transmissions from Hispaniola to" exact="Trinidad and Tobago" post="and to Jamaica between the late 1960s and the"/>
   <result pre="viral transmissions from Hispaniola to Trinidad and Tobago and to" exact="Jamaica" post="between the late 1960s and the early 1970s and"/>
   <result pre="late 1960s and the early 1970s and from Hispaniola and" exact="Trinidad and Tobago" post="to other Lesser Antilles islands at later times. Phylodynamics"/>
   <result pre="explored the origin of HIV-1 CRFs lineages recently detected in" exact="Brazil" post="that mostly circulate in West (CRF02_AG) and Central (CRF45_cpx)"/>
   <result pre="CRF45_cpx local clades indicated that these CRFs were circulating in" exact="Brazil" post="for about 20-30 years before their detection by the"/>
   <result pre="characterisation of a spatially localised iatrogenic outbreak occurred in rural" exact="Cambodia" post="in 2014-2015, suspected to be caused by an unlicensed"/>
   <result pre="the HIV-1 subtype C epidemic in heterosexual population from southern" exact="Brazil" post="support that major changes in viral transmission dynamics (transient"/>
   <result pre="subtype B lineages circulating in separate transmission networks in the" exact="United Kingdom" post="(UK) and also how the growth rate decrease of"/>
   <result pre="of HIV dissemination in geographic settings with huge epidemics like" exact="South Africa" post="and Uganda, respectively.28,29 De Oliveira et al.28 has shown"/>
   <result pre="the impact of public health interventions on HIV-1 transmission in" exact="Portugal" post="using molecular epidemiologyJ Infect Dis2019220223324330805610 19MirDGrafTAlmeidaSEMPintoARDelatorreEBelloGInferring population dynamics of"/>
   <result pre="of HIV-1 subtype C epidemics in Eastern Africa and Southern" exact="Brazil" post="applying different Bayesian phylodynamics approachesSci Rep2018818778877829884822 20HuéSPillayDClewleyJPPybusOGGenetic analysis reveals"/>
   <result pre="28de OliveiraTKharsanyABMGräfTCawoodCKhanyileDGroblerATransmission networks and risk of HIV infection in KwaZulu-Natal," exact="South Africa" post="a community-wide phylogenetic studyLancet HIV201741e41e5027914874 29GrabowskiMKLesslerJReddADKagaayiJLaeyendeckerONdyanaboAThe role of viral"/>
   <result pre="of viral introductions in sustaining community-based HIV epidemics in rural" exact="Uganda" post="evidence from spatial clustering, phylogenetics, and egocentric transmission modelsPLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7100926/results/search/country/results.xml">
   <result pre=": People and places : Geographical locations : South America:" exact="Brazil" post=": Research and Analysis Methods : Database and Informatics"/>
   <result pre="diversity and antiretroviral resistance in the state of Maranhão, Northeast" exact="Brazil" post="HIV-1 genetic diversity and antiretroviral resistance LealÉlcioConceptualizationFormal analysisInvestigationMethodologyProject administrationResourcesSupervisionWriting"/>
   <result pre="author and source are credited.pone.0230878.pdf Abstract The HIV-1 epidemic in" exact="Brazil" post="has been growing in northeast and north regions, particularly"/>
   <result pre="Supporting Information files. 1 Introduction Initially, the HIV epidemic in" exact="Brazil" post="was reported as the number of AIDS cases per"/>
   <result pre="of information systems [1]. The main HIV-1 subtypes found in" exact="Brazil" post="are B, F, C, and BF and BC recombinants"/>
   <result pre="BF and BC recombinants [2; 3; 4; 5; 6]. However," exact="Brazil" post="is a country of continental dimensions, with economic, social,"/>
   <result pre="to the large territorial proportion, the HIV-1 genetic diversity in" exact="Brazil" post="has regional characteristics with subtype B being the most"/>
   <result pre="proportion of other subtypes and/or recombinants. Some regions of Northeast" exact="Brazil" post="have a high proportion of subtype F (~30%) [5]"/>
   <result pre="available in a database of the Ministry of Health of" exact="Brazil" post="were obtained according to criteria for the evaluation of"/>
   <result pre="86.5%) and Pará (HIV-1 B = 90%) [25]. However, as" exact="Brazil" post="is a country of continental dimensions, there is variation"/>
   <result pre="by the high flux of tourists that came from Southeastern" exact="Brazil" post="which is the place of origin of recombinants 28"/>
   <result pre="against Efavirenz and Nevirapine, which was largely used NNRTIs in" exact="Brazil" post="as the recommended first-line regimen, being replaced, in 2017,"/>
   <result pre="no information about of sexual exposure. Another study in Northeast" exact="Brazil" post="[29] showed a higher number of men who have"/>
   <result pre="more likely to result in disease progression. Some studies in" exact="Brazil" post="have linked BF recombinants with faster progression to AIDS-defining"/>
   <result pre="PintoA.R., 2013The increasing prevalence of HIV-1 subtype C in Southern" exact="Brazil" post="and its dispersion through the continent. Virology. 453: 170–178."/>
   <result pre="HIV-1 Circulating Recombinant Forms CRF81_cpx and CRF99_BF1 in Central Western" exact="Brazil" post="and of Unique BF1 Recombinant Forms. Front Microbiol. 10:"/>
   <result pre="human immunodeficiency virus type 1 BF intersubtype recombinant viruses from" exact="Argentina" post="revealed by analysis of near full-length genome sequences. J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7101493/results/search/country/results.xml">
   <result pre="limited to subgroups of the population. Countries such as the" exact="United Kingdom," post="Georgia and Egypt are well on their way to"/>
   <result pre="subgroups of the population. Countries such as the United Kingdom," exact="Georgia" post="and Egypt are well on their way to reaching"/>
   <result pre="the population. Countries such as the United Kingdom, Georgia and" exact="Egypt" post="are well on their way to reaching the WHO"/>
   <result pre="References REFERENCES 1Norwegian Institute of Public Health. Tuberculosis (TB) in" exact="Norway" post="- fact sheet. Available: https://www.fhi.no/en/id/infectious-diseases/TB/tuberculosis-tb-in-norway—fact-sh/. Accessed: 20 November 2019."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7115234/results/search/country/results.xml">
   <result pre="support from the Natural Sciences and Engineering Research Council of" exact="Canada" post="and the James S. McDonnell Foundation Twenty-First Century Science"/>
   <result pre="direct and indirect protective effect of influenza vaccination in the" exact="United States." post="Am. J. Epidemiol.186, 92–100. (10.1093/aje/kwx037)28369163 19EpsteinSL, PriceGE2010Cross-protective immunity to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7144339/results/search/country/results.xml">
   <result pre="Establishment and recent surge in spatio-temporal spread of dengue in" exact="Nepal" post="Emerging Microbes &amp;amp; Infections K. P. Acharya et al."/>
   <result pre="krishna.acharya@nepal.gov.np, kriaasedu@gmail.comDepartment of Livestock Services (DLS), Animal Quarantine Office, Kathmandu," exact="Nepal" post="collection: 2020epub: 2020-3-391676679received: 2019-11-21rev-recd: 2020-3-02accepted: 2020-3-04(C) The Author(s), 2020This"/>
   <result pre="work is properly cited.TEMI_9_1740062.pdffig-count: table-count: equation-count: ref-count: page-count: Dear Editor," exact="Nepal" post="is vulnerable to the outbreak of many infectious diseases,"/>
   <result pre="diseases including Japanese encephalitis (JE), malaria, and dengue fever in" exact="Nepal" post="[3,4]. These diseases contribute significantly to socioeconomic burden in"/>
   <result pre="biggest global health crises. Dengue fever was first reported in" exact="Nepal" post="in 2004, and was followed by outbreaks that have"/>
   <result pre="now well established in the tropical and subtropical regions of" exact="Nepal" post="and is migrating towards the hilly region of the"/>
   <result pre="have been reported across 60 districts including the mid-hills of" exact="Nepal" post="(Figures 1 and 2). Large dengue outbreaks in Nepal"/>
   <result pre="of Nepal (Figures 1 and 2). Large dengue outbreaks in" exact="Nepal" post="occurred in 2010 (917 cases), 2013 (683 cases), and"/>
   <result pre="are present within the hosts, vectors, and the ecosystems of" exact="Nepal" post="[12]. In 2019, the worst epidemic to date developed"/>
   <result pre="number of confirmed dengue cases reported from different districts of" exact="Nepal" post="from fiscal year 2014/15 until 2019/20. Data were obtained"/>
   <result pre="of Nepal. The risk of dengue infection and outbreak in" exact="Nepal" post="is increasing year by year at different spatial scales"/>
   <result pre="Ministry of Health and Population (MoHP) of the Government of" exact="Nepal" post="(GoN) has developed an Early Warning and Reporting System"/>
   <result pre="occured. Generally, the temporal progress of an dengue epidemic in" exact="Nepal" post="intensifies over several months. Outbreaks following the monsoon season"/>
   <result pre="spatial and temporal disease projections are known, the government of" exact="Nepal" post="is failing to respond in a timely manner with"/>
   <result pre="&quot;National Guidelines of Prevention, Control &amp;amp; Management of Dengue in" exact="Nepal" post="2019&quot; in September 2019 [19]. Central, provincial, and local"/>
   <result pre="evaluate the spatial and temporal spread of dengue fever in" exact="Nepal" post="[9,21]. These studies have provided the basis of understanding"/>
   <result pre="References References 1collab: GoNNepal biodiversity strategy his majesty’s Government of" exact="Nepal" post="Ministry of Forests and Soil Conservation. Ministry of Forest"/>
   <result pre="MoritaK, et al.First case of dengue virus infection in Nepal." exact="Nepal" post="Med Coll J. 2004;6(2):157–159.16295753 9AcharyaBK, CaoC, LakesT, et al.Spatiotemporal"/>
   <result pre="9AcharyaBK, CaoC, LakesT, et al.Spatiotemporal analysis of dengue fever in" exact="Nepal" post="from 2010 to 2014. BMC Public Health. 2016. doi:"/>
   <result pre="infection in a French traveller to the hilly region of" exact="Nepal" post="in 2015: a case report. J Med Case Rep."/>
   <result pre="myRepublica – The New York Times Partner, Latest news of" exact="Nepal" post="in English, Latest News Articles. 2019 [cited 2019 Jul"/>
   <result pre="NepalNational guidelines on prevention, management and control of dengue in" exact="Nepal" post="2019 Government of Nepal, Ministry of Health and Population,"/>
   <result pre="ReliefwebMore than 30 people down with dengue in Hetauda -" exact="Nepal" post="_ ReliefWeb. 2019 [cited 2019 Sep 5]. Available from:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7171606/results/search/country/results.xml">
   <result pre="prevalence of HHV8 infection and HIV infection: Central, West, and" exact="South Africa" post="[4–8]. Stewart–Bluefarb syndrome is a form of pseudo-Kaposi corresponding"/>
   <result pre="bad prognosis. The regions of high endemicity are Latin America," exact="South Africa," post="and West and Central Africa, the region of origin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7185698/results/search/country/results.xml">
   <result pre="Vaccines : People and places : Geographical locations : Africa:" exact="Sierra Leone" post=": Medicine and Health Sciences : Tropical Diseases :"/>
   <result pre="– review &amp;amp; editing2[1], SmartAnalyst Inc., New York, New York," exact="United States" post="of America[2], SmartAnalyst India Pvt. Ltd., Gurgaon, India[3], Janssen"/>
   <result pre="Inc., New York, New York, United States of America[2], SmartAnalyst" exact="India" post="Pvt. Ltd., Gurgaon, India[3], Janssen Vaccines &amp;amp; Prevention, Raritan,"/>
   <result pre="Ltd., Gurgaon, India[3], Janssen Vaccines &amp;amp; Prevention, Raritan, New Jersey," exact="United States" post="of America[4], Janssen Vaccines &amp;amp; Prevention B.V., Leiden, The"/>
   <result pre="developed for this purpose and validated by simulating the 2014" exact="Sierra Leone" post="epidemic. We assessed the impacts of prophylactic vaccination of"/>
   <result pre="intervals [CI]: 478–21,942) cases and 3,575 (95%CI: 179–9,031) deaths in" exact="Sierra Leone," post="in line with WHO-reported statistics for the 2014 epidemic"/>
   <result pre="were employed by Janssen Vaccines &amp;amp; Prevention B.V., Leiden, The" exact="Netherlands" post="and RP, AK, VM and HB were employed by"/>
   <result pre="the later stages that an investigational vaccine was administered in" exact="Guinea" post="and Sierra Leone using a ring vaccination strategy [8,9]."/>
   <result pre="stages that an investigational vaccine was administered in Guinea and" exact="Sierra Leone" post="using a ring vaccination strategy [8,9]. Multiple Ebola vaccine"/>
   <result pre="followed by WHO prequalification), its subsequent independent approval by the" exact="United States" post="Food and Drug Administration, and submission of a prophylactic"/>
   <result pre="areas [12]. The persistent epidemic in the Democratic Republic of" exact="Congo" post="that has been ongoing since August 2018, with approximately"/>
   <result pre="model to reflect a real-life epidemic (we chose the 2014" exact="Sierra Leone" post="epidemic for the size of the epidemic and the"/>
   <result pre="model structure, and identification of data related to the 2014" exact="Sierra Leone" post="epidemic. This was followed by a) fitting of geography-"/>
   <result pre="mean outcomes with confirmed cases and deaths reported for the" exact="Sierra Leone" post="epidemic of 2014 by the WHO [28] and Fang"/>
   <result pre="P, protected. Model parameterization and validation The 2014 epidemic in" exact="Sierra Leone" post="was simulated with the help of disease-specific parameters that"/>
   <result pre="simulations, were compared with WHO data relating to the 2014" exact="Sierra Leone" post="epidemic to check for closeness of fit. Fig 2"/>
   <result pre="of fit. Fig 2 Reported Ebola cases for the 2014" exact="Sierra Leone" post="epidemic–among overall population (weekly cases) and in HCW (monthly"/>
   <result pre="the key model parameters were all based on the 2014" exact="Sierra Leone" post="epidemic. The vaccination strategy related parameters used in the"/>
   <result pre="(general population)/monthly (HCW) cases reported for the 2014 epidemic in" exact="Sierra Leone" post="separately for the three periods of the epidemic can"/>
   <result pre="consistent with previously published estimates of R0 for the 2014" exact="Sierra Leone" post="epidemic (1.26 &amp;lt; R0 &amp;lt; 2.53) [26]. Fig 3"/>
   <result pre="all HCW (115, who represent just 0.0016% of the overall" exact="Sierra Leone" post="population) will help reduce both cases and deaths at"/>
   <result pre="±10% range) in three key parameters fitted for the 2014" exact="Sierra Leone" post="epidemic—transmission rates, time to hospitalization, and time from hospitalization"/>
   <result pre="outbreaks similar to the one in Kikwit, Democratic Republic of" exact="Congo" post="(1995). However, the study concluded that while HCWs play"/>
   <result pre="will be. Kilmarx and colleagues [38], while evaluating the 2014" exact="Sierra Leone" post="epidemic, reported that cumulative incidence in HCW was 8,285"/>
   <result pre="&amp;gt;51% (95% confidence intervals: 44%-56%) of the total population in" exact="Sierra Leone" post="would be sufficient to control the epidemic of Ebola"/>
   <result pre="HCW workforce in the affected countries of Guinea, Liberia, and" exact="Sierra Leone," post="died during the 2014 epidemic [33,40]. This made it"/>
   <result pre="percent of surgeons affiliated with the main teaching hospital in" exact="Sierra Leone" post="died during the epidemic in August 2014, resulting in"/>
   <result pre="in maternal mortality by 38%, 74%, and 111% in Guinea," exact="Sierra Leone," post="and Liberia, respectively, translating to 4,022 additional maternal deaths"/>
   <result pre="outbreak, and 3) the impact of ring vaccination implemented in" exact="Sierra Leone" post="during the 2014 epidemic has been captured during the"/>
   <result pre="vaccine in preventing Ebola virus disease: final results from the" exact="Guinea" post="ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet"/>
   <result pre="14collab: World Health Organization. Ebola virus disease–Democratic Republic of the" exact="Congo" post="Disease outbreak news: Update; 28 February 2019Geneva, Switzerland: World"/>
   <result pre="2018 Ebola virus disease outbreak in Equateur province in the" exact="Democratic Republic of the Congo." post="bioRxiv. 2019:46506210.1101/465062 22WordenL, WannierR, HoffNA, MuseneK, SeloB, MossokoM, et"/>
   <result pre="MartchevaM. Efficacy of control measures in the control of Ebola," exact="Liberia" post="2014–2015. J Biol Dyn. 2018;12(1):913–37. Epub 2018/10/26. 10.1080/17513758.2018.153509530355048 24WellsCR,"/>
   <result pre="PandeyA, ParpiaAS, FitzpatrickMC, MeyersLA, SingerBH, et al.Ebola vaccination in the" exact="Democratic Republic of the Congo." post="Proceedings of the National Academy of Sciences of the"/>
   <result pre="Congo. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America. 2019;116(20):10178–83. Epub 2019/05/01. 10.1073/pnas.181732911631036657 25RobertA, CamachoA, EdmundsWJ,"/>
   <result pre="The potential impact of a prophylactic vaccine for Ebola in" exact="Sierra Leone." post="Mathematical biosciences and engineering: MBE. 2018;15(2):337–59. Epub 2017/11/23. 10.3934/mbe.201801529161839"/>
   <result pre="al.Transmission dynamics of Ebola virus disease and intervention effectiveness in" exact="Sierra Leone." post="Proceedings of the National Academy of Sciences of the"/>
   <result pre="Leone. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America. 2016;113(16):4488–93. Epub 2016/04/02. 10.1073/pnas.151858711327035948 30GillespieDT. A general"/>
   <result pre="Ebola: how events impacted on a single surgical institution in" exact="Sierra Leone." post="J R Army Med Corps. 2016;162(3):212–6. Epub 2016/01/21. 10.1136/jramc-2015-00058226787775"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7193772/results/search/country/results.xml">
   <result pre="Marine Scotland ScienceAberdeenUnited Kingdom Edited by: Feng Gao, Tianjin University," exact="China" post="Reviewed by: Espen Rimstad, Norwegian University of Life Sciences,"/>
   <result pre="Sciences, Norway; Aase B. Mikalsen, Norwegian University of Life Sciences," exact="Norway" post="*Correspondence: Michael D. Gallagher, mike.d.gallagher.16@gmail.com This article was submitted"/>
   <result pre="in European aquaculture. SAV is classified into six subtypes, with" exact="Norway" post="having ongoing epidemics of SAV subtypes 2 and 3."/>
   <result pre="with Scotland reporting cases of SAV1, SAV2, SAV4, and SAV5," exact="Ireland" post="reporting cases of SAV1, SAV2, SAV5, SAV6 (Graham et"/>
   <result pre="of SAV1, SAV2, SAV5, SAV6 (Graham et al., 2012), and" exact="Norway" post="presenting sustained epidemics of SAV2 and SAV3 (Hodneland et"/>
   <result pre="studies (Karlsen et al., 2014). Both SAV subtypes present in" exact="Norway" post="are geographically structured with the counties of Rogaland and"/>
   <result pre="et al., 2014) and length of the SAV3 epidemic in" exact="Norway" post="(Poppe et al., 1989; Hjortaas et al., 2016). However,"/>
   <result pre="error rate. Results We sequenced 24 SAV3-infected fish hearts from" exact="Norway" post="using an overlapping PCR amplicon approach and the MinION"/>
   <result pre="this may have been the ancestral genotype of SAV3 in" exact="Norway" post="before splitting into two clades. Moreover, while strains sampled"/>
   <result pre="all represented in a relatively limited geographical area of Western" exact="Norway" post="during the same timeframe. The clades did not show"/>
   <result pre="Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss in" exact="Norway" post="(Diseases of Aquatic Organisms (2005) 66 (113-120)).Dis. Aquat. Organ.67:181."/>
   <result pre="(PD) outbreaks in farmed Atlantic salmon and rainbow trout in" exact="Norway" post="during 2003-2007.Prev. Vet. Med.90127–136. 10.1016/j.prevetmed.2009.04.00319419787 LemeyP.RambautA.DrummondA. J.SuchardM. A. (2009)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7205173/results/search/country/results.xml">
   <result pre="double-blind corticosteroid therapy.Arch Ophthalmol1970;84:36–40.4316409 9DawsonCRHannaLWoodTRDespainRAdenovirus type 8 keratoconjunctivitis in the" exact="United States." post="3. Epidemiologic, clinical, and microbiologic features.AJOPHT1970;69:473–480. 10BoniukMPhillipsCAFriedmanJBChronic adenovirus type"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7210410/results/search/country/results.xml">
   <result pre="Biomarkers Human erythroparvovirus B19 Blood donor Blood safety Persistent infection" exact="Argentina" post="1 Introduction Human parvovirus B19 (B19V, Erythroparvovirus primate 1"/>
   <result pre="was approved by the Ethics Committee of Hospital Rawson, Córdoba," exact="Argentina" post="(05082015). 2.2 Study sample The study population included men"/>
   <result pre="using a representative sample. Analogous frequency have been documented in" exact="Brazil" post="(1.1%) [21], Chile (0.8%) [28], United Kingdom (0.9%) and"/>
   <result pre="sample. Analogous frequency have been documented in Brazil (1.1%) [21]," exact="Chile" post="(0.8%) [28], United Kingdom (0.9%) and Ghana (1.3%) [29],"/>
   <result pre="have been documented in Brazil (1.1%) [21], Chile (0.8%) [28]," exact="United Kingdom" post="(0.9%) and Ghana (1.3%) [29], South Africa (0.9%) [19]"/>
   <result pre="Brazil (1.1%) [21], Chile (0.8%) [28], United Kingdom (0.9%) and" exact="Ghana" post="(1.3%) [29], South Africa (0.9%) [19] and the United"/>
   <result pre="Chile (0.8%) [28], United Kingdom (0.9%) and Ghana (1.3%) [29]," exact="South Africa" post="(0.9%) [19] and the United States (0.9%) [30]. At"/>
   <result pre="and Ghana (1.3%) [29], South Africa (0.9%) [19] and the" exact="United States" post="(0.9%) [30]. At global level, the detection rate seems"/>
   <result pre="controls in 2007 and 2012 [24,38] and the prevalence in" exact="Chile" post="(55%), Brazil (60%), Australia and England (60%) [29, 44,"/>
   <result pre="2007 and 2012 [24,38] and the prevalence in Chile (55%)," exact="Brazil" post="(60%), Australia and England (60%) [29, 44, 45, 46]."/>
   <result pre="2012 [24,38] and the prevalence in Chile (55%), Brazil (60%)," exact="Australia" post="and England (60%) [29, 44, 45, 46]. Some attribute"/>
   <result pre="B19 and detection of an unusual genotype 2 variant ," exact="Bulgaria" post=", 2004 to 2013Euro Surveill.21201618 36MorO.OfirI.PavelR.BassalR.CohenD.ShohatT.MendelsonE.Parvovirus B19V infection in"/>
   <result pre="Bulgaria , 2004 to 2013Euro Surveill.21201618 36MorO.OfirI.PavelR.BassalR.CohenD.ShohatT.MendelsonE.Parvovirus B19V infection in" exact="Israel" post=": prevalence and occurrence of acute infection between 2008"/>
   <result pre="researchLupus1920101557156020679283 47KellyH.A.SiebertD.HammondR.LeydonJ.KielyP.MaskillW.The age-specific prevalence of human parvovirus immunity in Victoria," exact="Australia" post="compared with other parts of the worldEpidemiol. Infect.124200044945710982069 48PorignauxR.VuibletV.BarbeC.NguyenY.LavaudS.ToupanceO.AndreolettiL.RieuP.LevequeN.A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7219790/results/search/country/results.xml">
   <result pre="Humidity : People and Places : Geographical Locations : Asia:" exact="Singapore" post=": Medicine and Health Sciences : Infectious Diseases: Infectious"/>
   <result pre="Saw Swee Hock School of Public Health, National University of" exact="Singapore" post="and National University Health System, Singapore[2], Environmental Health Institute,"/>
   <result pre="regimes. BRS estimates epidemic and endemic regimes of dengue in" exact="Singapore" post="which are characterized by persistence across time, lasting an"/>
   <result pre="study are available from Environmental Health Institute, National Environmental Agency," exact="Singapore" post="(nea.gov.sg). Point of contact: Joel Aik, Deputy Director, Environmental"/>
   <result pre="Joel Aik, Deputy Director, Environmental Health Institute, National Environmental Agency," exact="Singapore" post="Joel_Aik@nea.gov.sg. Introduction An estimated 390 million dengue infections occur"/>
   <result pre="two dengue mosquito vectors Aedes aegypti and Aedes albopictus in" exact="Singapore" post="[3]. The low seroprevalence rates across the national population"/>
   <result pre="periods [18]. Martinez et al. explored influenza epidemic detection in" exact="Spain" post="using a regime switching framework where highly seasonal dynamics"/>
   <result pre="are highly noncyclical with varying temporal lengths across time in" exact="Singapore" post="(Figs 1 and 2). Although 3 regimes were considered"/>
   <result pre="temperature and humidity for dengue counts were previously discussed for" exact="Singapore" post="[21,22] and other countries [23–25], along with preliminary estimation"/>
   <result pre="Dengue incidence data is collected by the Ministry of Health," exact="Singapore" post="with mandatory notification of virologically confirmed or laboratory-confirmed cases"/>
   <result pre="2017. The Institutional Review Board of the National University of" exact="Singapore" post="provided the ethical approval for this study. Climate data"/>
   <result pre="837–859. 10.1016/j.jmoneco.2003.09.003 18StruchinerCJ, RocklövJ, Wilder-SmithA, MassadE. Increasing Dengue Incidence in" exact="Singapore" post="over the Past 40 Years: Population Growth, Climate and"/>
   <result pre="Local and Global Effects of Climate on Dengue Transmission in" exact="Puerto Rico." post="PLoS Negl Trop Dis. 2009;3: e38210.1371/journal.pntd.000038219221592 24HiiYL, ZhuH, NgN,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7225908/results/search/country/results.xml">
   <result pre="Report on Hand-Foot-and-Mouth Disease and Epidemic Parotitis in Hanzhong City," exact="China" post="WeiJianjun1ZhuZhonghai2QiQi2https://orcid.org/0000-0002-4649-9818ZengLingxiatjzlx@mail.xjtu.edu.cn2[], 1[], 2 Academic Editor: Maria Lina Tornesello collection:"/>
   <result pre="in collective units, such as schools and childcare centers [2]." exact="China" post="has included it in the disease surveillance information report"/>
   <result pre="reported incidence of epidemic parotitis between 2004 and 2010 in" exact="China" post="fluctuated around 20/100,000 [4]. However, in 2008 and 2009,"/>
   <result pre="parotitis outbreaks. Since 2004, the incidence of epidemic parotitis in" exact="China" post="has been highest among children &amp;lt;15 years, which accounted"/>
   <result pre="disease onset [4]. Recently, the hand-foot-and-mouth disease (HFMD) epidemic in" exact="China" post="has shown characteristics of a fairly high incidence rate"/>
   <result pre="epidemic [9]. After 2008, medical institutes in each level in" exact="China" post="were required to report the HFMD cases directly through"/>
   <result pre="system according to the &quot;Law of the People's Republic of" exact="China" post="on the prevention and treatment of infectious disease.&quot; Cases"/>
   <result pre="regulations stated in the &quot;Law of the People's Republic of" exact="China" post="on the prevention and treatment of infectious disease&quot; and"/>
   <result pre="Office of the State Council of the People's Republic of" exact="China" post="each year. The day before the statutory holiday was"/>
   <result pre="and the coauthors reported a steady incidence of mumps in" exact="China" post="between 2004 and 2013 [19], surrounding around the rate"/>
   <result pre="study. The incidence of HMFD showed an increasing tendency in" exact="China" post="from 2008 to 2017 [9], but no corresponding increment"/>
   <result pre="highest occurrence of outbreak reporting in healthcare facilities from Toronto," exact="Canada" post="[36], and the authors concluded the health staff differences"/>
   <result pre="work was supported by the National Natural Science Foundation of" exact="China" post="(grant no. 81872633) and National Key Research and Development"/>
   <result pre="no. 81872633) and National Key Research and Development Program of" exact="China" post="(grant nos. 2017YFC0907200 and 2017YFC0907201). Abbreviations HFMD: Hand-foot-and-mouth disease."/>
   <result pre="data file. References 1JiangR.YinQ.XuM.et al.Epidemiological characteristics of mumps in mainland" exact="China" post="from 2004 to 2018 and key population for prevention"/>
   <result pre="School Health201940513 3BoF.CuiA.GuoX.Analysis epidemiological and pathogen characters of mumps in" exact="China" post="from 2004 to 2006Chinese Journal of Vaccines and Immunization2009152"/>
   <result pre="Preventive Medicine2015421526892691 5MaJ.HaoL.LuoH.et al.Analysis on epidemiological characteristics of mumps in" exact="China" post="during 2008-2009Chinese Journal of Vaccines and Immunization2010166533535 6HuY.HaoL.WangH.Analysis on"/>
   <result pre="Standard)2015ChinaChinese Technical Publication 19SuQ. R.LiuJ.MaC.et al.Epidemic profile of mumps in" exact="China" post="during 2004–2013Zhonghua Yu Fang Yi Xue Za Zhi201650761161427412837 20SunJ.YangW."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7232143/results/search/country/results.xml">
   <result pre="7232143 doi: 10.3390/v12040448viruses-12-00448 : Article West Nile Virus Epidemic in" exact="Germany" post="Triggered by Epizootic Emergence, 2019 ZieglerUte12†SantosPauline Dianne3†GroschupMartin H.12HattendorfCarolin4https://orcid.org/0000-0002-1197-8288EidenMartin1https://orcid.org/0000-0001-8408-2274HöperDirk3EisermannPhilip4KellerMarkus1MichelFriederike1KlopfleischRobert5MüllerKerstin6WernerDoreen7KampenHelge8BeerMartin3FrankChristina9LachmannRaskit9https://orcid.org/0000-0002-8647-0497TewsBirke Andrea8WylezichClaudia3https://orcid.org/0000-0003-3269-7407RinderMonika10LachmannLars11https://orcid.org/0000-0002-2955-3085GrünewaldThomas12SzentiksClaudia"/>
   <result pre="and five confirmed mosquito-borne, autochthonous human cases. We demonstrated that" exact="Germany" post="experienced several WNV introduction events and that strains of"/>
   <result pre="distinct group (Eastern German WNV clade), which was introduced to" exact="Germany" post="as a single introduction event, dominated mosquito, birds, horse"/>
   <result pre="This study highlights the risk of a further spread in" exact="Germany" post="in the next years with additional human WNV infections."/>
   <result pre="warning and thus, initiate targeted control measures. West Nile virus" exact="Germany" post="epizooty epidemic human bird horses mosquitoes transmission risk zoonoses"/>
   <result pre="main focus of WNV circulation is in south-eastern Europe and" exact="Italy" post="[7]. However, low WNV activity is also observed in"/>
   <result pre="WNV activity is also observed in the neighboring countries of" exact="Germany" post="(France, Austria, and Czech Republic). Therefore, over the last"/>
   <result pre="over the last decade, different monitoring programs were implemented in" exact="Germany" post="to screen for WNV RNA and antibodies in birds,"/>
   <result pre="In 2018, an epizootic emergence of WNV was observed in" exact="Germany" post="for the first time [13]. All WNV-positive birds and"/>
   <result pre="central European subclade II. WNV activity was detected in eastern" exact="Germany" post="over a distance of almost 900 km (Munich to"/>
   <result pre="However, phylogenetic analysis in combination with the wide distribution in" exact="Germany" post="indicates that WNV may have been introduced from the"/>
   <result pre="Germany indicates that WNV may have been introduced from the" exact="Czech Republic" post="to Germany already before 2018 [13]. The emergence of"/>
   <result pre="WNV may have been introduced from the Czech Republic to" exact="Germany" post="already before 2018 [13]. The emergence of WNV in"/>
   <result pre="Germany already before 2018 [13]. The emergence of WNV in" exact="Germany" post="and the focus in the central part of eastern"/>
   <result pre="Germany and the focus in the central part of eastern" exact="Germany" post="was correlated with outstandingly high summer temperatures. As demonstrated"/>
   <result pre="biotype pipiens, Culex pipiens biotype molestus and Culex torrentium from" exact="Germany" post="were experimentally proven to be susceptible to WNV infection"/>
   <result pre="extrinsic incubation period (EIP). Phylogenetic and phylogeographic analysis showed that" exact="Germany" post="experienced several WNV introduction events. Several virus variants circulate"/>
   <result pre="Several virus variants circulate in the affected German regions with" exact="Austria" post="and Czech Republic as possible origins. The majority of"/>
   <result pre="variants circulate in the affected German regions with Austria and" exact="Czech Republic" post="as possible origins. The majority of the WNV strains"/>
   <result pre="Mosquitoes Since the first outbreak of Usutu virus (USUV) in" exact="Germany" post="(2011/12), a nationwide bird surveillance network (living and dead"/>
   <result pre="infection in birds and horses is a notifiable disease in" exact="Germany" post="if a recent infection is detected by a WNV-specific"/>
   <result pre="2019), all WNV-positive animals originated from the eastern part of" exact="Germany" post="with a distinct focus for the federal states Saxony-Anhalt,"/>
   <result pre="WNV circulation was similar in 2018 and 2019, i.e., central-eastern" exact="Germany" post="with most WNV-positive samples (mosquitoes, birds and horses) (Figure"/>
   <result pre="and yellow fever virus. The first mosquito-borne, autochthonous infection for" exact="Germany" post="was confirmed in Leipzig, Federal State of Saxony on"/>
   <result pre="Central and Eastern European clade (CEC). All WNV strains from" exact="Germany" post="fell into the CEC (Figure 2). The detailed analysis"/>
   <result pre="(Figure 2). However, the majority of the WNV strains from" exact="Germany" post="clustered into a well defined monophyletic group designated as"/>
   <result pre="the WNV strains from birds, horses, mosquitoes and humans in" exact="Germany" post="were observed. The genetic variations of WNV combined with"/>
   <result pre="analysis suggests at least six distinct introductions of WNV into" exact="Germany" post="from neighboring countries. It is predicted that all viral"/>
   <result pre="number of more current WNV strains from e.g., Austria, the" exact="Czech Republic," post="and Poland would help to answer the circumstances of"/>
   <result pre="current WNV strains from e.g., Austria, the Czech Republic, and" exact="Poland" post="would help to answer the circumstances of when and"/>
   <result pre="a very recent emergence which was most likely introduced into" exact="Germany" post="as a single introduction event. The progenitor of this"/>
   <result pre="European clade dates back to 2011, most probably circulating in" exact="Czech Republic" post="(95% HPD 2010–2012; posterior probability, pp = 0.88) (Figure"/>
   <result pre="The EGC shares a common ancestor with basal WNV from" exact="Germany" post="providing strong support for in situ evolution of WNV"/>
   <result pre="providing strong support for in situ evolution of WNV in" exact="Germany" post="(Figure 3 and Figure 4). Except for the members"/>
   <result pre="the EGC, all other WNV strains found most recently in" exact="Germany" post="seem to be descendants of ancestors from Austria (95%"/>
   <result pre="recently in Germany seem to be descendants of ancestors from" exact="Austria" post="(95% HPD for 2000 to 2015; pp = 0.83−0.97)."/>
   <result pre="pp = 0.83−0.97). The spatial diffusion pattern of WNV within" exact="Germany" post="and between Germany and neighboring countries has been reconstructed"/>
   <result pre="The spatial diffusion pattern of WNV within Germany and between" exact="Germany" post="and neighboring countries has been reconstructed using a Bayes"/>
   <result pre="detected between Austria–Germany and Czech Republic–Germany, while the links within" exact="Germany" post="have been detected between Halle–Berlin, Berlin–Halle, Berlin–Hamburg, Berlin–Dresden and"/>
   <result pre="to be common for EGC strains and some WNV from" exact="Austria" post="(MF984341), Czech Republic (KM203862) and Germany (LR743437 and LR743434)."/>
   <result pre="common for EGC strains and some WNV from Austria (MF984341)," exact="Czech Republic" post="(KM203862) and Germany (LR743437 and LR743434). There are several"/>
   <result pre="and some WNV from Austria (MF984341), Czech Republic (KM203862) and" exact="Germany" post="(LR743437 and LR743434). There are several non-synonymous mutations in"/>
   <result pre="eco-epidemiological factors that facilitate WNV becoming an established pathogen in" exact="Germany" post="causing neuroinvasive disease in multiple vertebrate species, including humans."/>
   <result pre="first observed autochthonous WNV transmission to birds and horses in" exact="Germany" post="[9,13], an epizootic emergence of WNV was again observed"/>
   <result pre="the speculation that hundreds of undetected human WNV infections in" exact="Germany" post="occurred during the epidemic in 2019. WNV transmission and"/>
   <result pre="high temperatures allowing low EIP values. The area in central-eastern" exact="Germany" post="as the main focus of WNV circulation in both"/>
   <result pre="EIP compared to previous years and most other areas in" exact="Germany" post="[13]. Furthermore, these areas in Germany are directly neighboring"/>
   <result pre="most other areas in Germany [13]. Furthermore, these areas in" exact="Germany" post="are directly neighboring countries reporting several years of WNV"/>
   <result pre="that the areas along the Upper Rhine Valley in south-west" exact="Germany" post="had a high suitability for WNV circulation, but no"/>
   <result pre="suitable vector or host species). The phylogenetic analyses indicated that" exact="Germany" post="experienced at least six distinct WNV introduction events, with"/>
   <result pre="Germany experienced at least six distinct WNV introduction events, with" exact="Austria" post="and Czech Republic as possible origin for the progenitors"/>
   <result pre="at least six distinct WNV introduction events, with Austria and" exact="Czech Republic" post="as possible origin for the progenitors of the German"/>
   <result pre="variants took place and how descendants were eventually transferred to" exact="Germany" post="remains elusive. However, such a translocation and subsequent virus"/>
   <result pre="fostered by the extremely favorable climatic conditions for mosquitos in" exact="Germany" post="in spring/summer 2018, and the short distance transmission with"/>
   <result pre="has been a comprehensive USUV/WNV monitoring system in place in" exact="Germany" post="for over a decade which involves ornithologists, zoological gardens"/>
   <result pre="there has been an exhaustive mosquito surveillance in place in" exact="Germany" post="since 2009. By both surveillance approaches a variety of"/>
   <result pre="supports a recent introduction of multiple WNV descendants e.g., from" exact="Czech Republic" post="to Germany. However, sequencing a larger number of more"/>
   <result pre="a larger number of more current WNV strains from e.g.," exact="Austria" post="or the Czech Republic would help to answer the"/>
   <result pre="of more current WNV strains from e.g., Austria or the" exact="Czech Republic" post="would help to answer the circumstances of when and"/>
   <result pre="using NGS-based approaches. Most of the singleton WNV variants in" exact="Germany" post="do not contain the monophyletic Lys2114Arg mutation located in"/>
   <result pre="enzootic maintenance similar to that observed for WNV in the" exact="United States" post="[38,39]. This hypothesis is supported by the observation that"/>
   <result pre="sets. The purifying and negative selections observed for WNV in" exact="Germany" post="were expected given the transmission and infection modes of"/>
   <result pre="comprehensive summary and phylogeographic analysis on the WNV epidemic in" exact="Germany" post="in 2018 and 2019 and highlights the risk of"/>
   <result pre="to PD habil. Norbert Becker, German Mosquito Control Association, Speyer," exact="Germany" post="and Stefan Bosch, Nature and Biodiversity Conservation Union, Stuttgart,"/>
   <result pre="Germany and Stefan Bosch, Nature and Biodiversity Conservation Union, Stuttgart," exact="Germany" post="for the collection and submission of dead birds. We"/>
   <result pre="the different bird clinics, rehabilitation centers and zoological gardens of" exact="Germany" post="as partners in the nation-wide wild bird surveillance network"/>
   <result pre="2818SE001, the German Federal Ministry of Education and Research of" exact="Germany" post="(BMBF) with the grant number 01EI1702A, the German Center"/>
   <result pre="GermanyVet. Microbiol.201923910845310.1016/j.vetmic.2019.10845331767092 38.AñezG.GrinevA.ChanceyC.BallC.AkolkarN.LandK.J.WinkelmanV.StramerS.L.KramerL.D.RiosM.Evolutionary dynamics of West Nile virus in the" exact="United States," post="1999–2011: Phylogeny, selection pressure and evolutionary time-scale analysisPLoS Negl."/>
   <result pre="framed snapshots of the dispersal patterns (2018–2019) among regions in" exact="Germany" post="for the Eastern German WNV clade. Lines between locations"/>
   <result pre="with where the relevant location transition occurs. All introductions for" exact="Germany" post="are shown. Circle diameters of locations are proportional to"/>
   <result pre="Viral migration patterns are indicated between the different regions of" exact="Germany" post="and neighboring countries and are proportional to the strength"/>
   <result pre="horses and mosquito-borne, autochthonous humans for the federal states of" exact="Germany" post="in 2018/2019. Numbers in brackets indicate the number of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7236962/results/search/country/results.xml">
   <result pre="a result of vaccination, in some countries such as the" exact="United States," post="there are no longer periodically severe epidemics of EEEV"/>
   <result pre="outbreaks that covered western North America, extending northward into Saskatchewan," exact="Canada" post="[7], the epizootic reached the east side of the"/>
   <result pre="in mosquito pools since 2008. The WEEV was isolated in" exact="Argentina" post="in 2009. Subsequently, an outbreak in Uruguay resulted in"/>
   <result pre="was isolated in Argentina in 2009. Subsequently, an outbreak in" exact="Uruguay" post="resulted in a fatal human case [11] (Fig. 1)."/>
   <result pre="were only three reported cases of EEEV in humans in" exact="Brazil" post="and Trinidad. Unlike the epidemiological profile in South America,"/>
   <result pre="and outbreaks have been reported in Venezuela, Colombia, Ecuador, Panama," exact="Costa Rica," post="Nicaragua Guatemala, Honduras, Salvador, Panama, Mexico and the United"/>
   <result pre="have been reported in Venezuela, Colombia, Ecuador, Panama, Costa Rica," exact="Nicaragua" post="Guatemala, Honduras, Salvador, Panama, Mexico and the United States"/>
   <result pre="Colombia, Ecuador, Panama, Costa Rica, Nicaragua Guatemala, Honduras, Salvador, Panama," exact="Mexico" post="and the United States [1]. The VEEV has enzootic"/>
   <result pre="Costa Rica, Nicaragua Guatemala, Honduras, Salvador, Panama, Mexico and the" exact="United States" post="[1]. The VEEV has enzootic and epizootic serotypes. Within"/>
   <result pre="so far only in Brazil; Subtype (V) Cabassou. Isolated in" exact="French Guiana" post="mosquitoes; Subtype (VI). AG8O-663. Isolated in mosquitoes from Argentina"/>
   <result pre="French Guiana mosquitoes; Subtype (VI). AG8O-663. Isolated in mosquitoes from" exact="Argentina" post="[18, 20] (Table 1). Table 1 Subtypes and serotypes"/>
   <result pre="[29]. VEEV in bats of America. In 1970 in Oxaca," exact="Mexico" post="was found a vampire bat D. rotundus infected with"/>
   <result pre="serve as an alternative host for virus maintenance [15]. In" exact="Trinidad and Tobago," post="a seroprevalence study was carried out against antibodies selected"/>
   <result pre="reached Trinidad (Table 2) [36]. Additional epizootics were reported in" exact="Peru" post="from 1942 to 1946 [25, 37]. One of the"/>
   <result pre="humans in the Americas, 1935–2011 Year Country Equines Humans 1935" exact="Colombia" post="Unknown – 1935–1943 Colombia Unknown – 1935–1943 Venezuela Unknown"/>
   <result pre="1935–2011 Year Country Equines Humans 1935 Colombia Unknown – 1935–1943" exact="Colombia" post="Unknown – 1935–1943 Venezuela Unknown – 1942–1946 Peru Unknown"/>
   <result pre="– 1935–1943 Colombia Unknown – 1935–1943 Venezuela Unknown – 1942–1946" exact="Peru" post="Unknown – 1943 Trinidad Unknown – 1962 Colombia Unknown"/>
   <result pre="– 1942–1946 Peru Unknown – 1943 Trinidad Unknown – 1962" exact="Colombia" post="Unknown 3000 1962 Venezuela Unknown 23,283 1967–1968 Colombia Unknown"/>
   <result pre="– 1962 Colombia Unknown 3000 1962 Venezuela Unknown 23,283 1967–1968" exact="Colombia" post="Unknown Unknown 1967–1968 Venezuela Unknown Unknown 1969 Ecuador 20,000"/>
   <result pre="23,283 1967–1968 Colombia Unknown Unknown 1967–1968 Venezuela Unknown Unknown 1969" exact="Ecuador" post="20,000 31,000 1969 El Salvador Unknown Unknown 1969 Guatemala"/>
   <result pre="Unknown 1967–1968 Venezuela Unknown Unknown 1969 Ecuador 20,000 31,000 1969" exact="El Salvador" post="Unknown Unknown 1969 Guatemala Unknown Unknown 1969 Mexico 50,000"/>
   <result pre="1969 Ecuador 20,000 31,000 1969 El Salvador Unknown Unknown 1969" exact="Guatemala" post="Unknown Unknown 1969 Mexico 50,000 Unknown 1969 Other CA"/>
   <result pre="1969 El Salvador Unknown Unknown 1969 Guatemala Unknown Unknown 1969" exact="Mexico" post="50,000 Unknown 1969 Other CA countries Unknown Unknown 1971"/>
   <result pre="Other CA countries Unknown Unknown 1971 USA 2000 110 1972" exact="Mexico" post="Unknown – 1992 Venezuela Unknown Unknown 1993 Venezuela Unknown"/>
   <result pre="– 1992 Venezuela Unknown Unknown 1993 Venezuela Unknown Unknown 1993" exact="Mexico" post="Unknown – 1995 Venezuela 4000 100,000 Colombia 1996 Mexico"/>
   <result pre="Unknown Unknown 1993 Mexico Unknown – 1995 Venezuela 4000 100,000" exact="Colombia" post="1996 Mexico Unknown – 1998 Colombia Unknown 250 2011"/>
   <result pre="1993 Mexico Unknown – 1995 Venezuela 4000 100,000 Colombia 1996" exact="Mexico" post="Unknown – 1998 Colombia Unknown 250 2011 Colombia 4"/>
   <result pre="1995 Venezuela 4000 100,000 Colombia 1996 Mexico Unknown – 1998" exact="Colombia" post="Unknown 250 2011 Colombia 4 foci – 2011 Venezuela"/>
   <result pre="Colombia 1996 Mexico Unknown – 1998 Colombia Unknown 250 2011" exact="Colombia" post="4 foci – 2011 Venezuela 3 foci – During"/>
   <result pre="2). At the end of 1969, epizootics were reported in" exact="El Salvador" post="and Guatemala; these outbreaks eventually spread to most of"/>
   <result pre="these outbreaks eventually spread to most of Central America and" exact="Mexico" post="[38–40]. During this outbreak, about 50,000 horses died, in"/>
   <result pre="about 52,000 human cases, of which 93 were fatal in" exact="Mexico" post="[41, 42]. Initially, the deaths of horses in Mexico"/>
   <result pre="in Mexico [41, 42]. Initially, the deaths of horses in" exact="Mexico" post="were reported in the state of Chiapas, this outbreak"/>
   <result pre="followed by additional outbreaks in 1993 in both Venezuela and" exact="Mexico" post="[40] (Fig. 2; Table 2). In 1995, both Venezuela"/>
   <result pre="[40] (Fig. 2; Table 2). In 1995, both Venezuela and" exact="Colombia" post="reported outbreaks [44] involving some 100,000 human cases, of"/>
   <result pre="with this outbreak. Small equine epizootics were also reported in" exact="Mexico" post="in 1993 and 1996 [40] (Fig. 2; Table 2)."/>
   <result pre="Las encephalitis equinas en la salud pública. Universidad Nacional de" exact="Colombia" post="Press. Facultad de Medicina Veterinaria y de Zootecnia. 2005;"/>
   <result pre="equine encephalomyelitis: surveys of human illness during an epizootic in" exact="Guatemala" post="and El SalvadorAm J Epidemiol19719321301365101138 40.ObersteMSWeaverSCWattsDMSmithJFIdentification and genetic analysis"/>
   <result pre="ColombiaAm J Trop Med Hyg.195982 Pt 117518913637316 49.Sanmartin-BarberiCGrootHOsorno-MesaEHuman epidemic in" exact="Colombia" post="caused by the Venezuelan equine encephalomyelitis virusAm J Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7237993/results/search/country/results.xml">
   <result pre="swine causes substantial economic losses to the pig industry in" exact="China" post="and other countries. In China, the occurrence of PED"/>
   <result pre="[1]. In the winter of 2010, PED outbreaks occurred in" exact="China" post="and cause large economic losses [2]. Subsequently, in spring"/>
   <result pre="Meanwhile, the average temperature in the cold region of northeast" exact="China" post="was during −5 °C to 5 °C. So we"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7241453/results/search/country/results.xml">
   <result pre="Institute of Microbiology and Epidemiology, Beijing 100071, People’s Republic of" exact="China" post="Li-Qun Fang fang_lq@163.comState Key Laboratory of Pathogen and Biosecurity,"/>
   <result pre="Institute of Microbiology and Epidemiology, Beijing 100071, People’s Republic of" exact="China" post="*Dong Miao and Ke Dai contributed equally to this"/>
   <result pre="receptivity to H. longicornis across two continents, including northeastern USA," exact="New Zealand," post="parts of Australia, and several Pacific islands. Eight key"/>
   <result pre="parts of the Korean peninsula and southern Japan, and northern" exact="New Zealand." post="Our findings highlight areas where an intensive vigilance for"/>
   <result pre="Haemaphysalis longicornis machine learning modelling distribution risk assessment world Funding" exact="China" post="Mega-Project for Infectious Diseases2018ZX102010012018ZX107130022018ZX10101003 National Natural Science Foundation of"/>
   <result pre="study was supported by the National Natural Science Foundation of" exact="China" post="[grant number 81825019], the China Mega-Project for Infectious Diseases"/>
   <result pre="National Natural Science Foundation of China [grant number 81825019], the" exact="China" post="Mega-Project for Infectious Diseases [grant numbers 2018ZX10201001, 2018ZX10713002, and"/>
   <result pre="(CFR) of 12‒50% [1,2]. The disease was first identified in" exact="China" post="in 2009 but retrospectively traced back to human cases"/>
   <result pre="back to human cases in 2007 [3,4]. South Korea and" exact="Japan" post="both reported their first cases in 2013, and were"/>
   <result pre="Very recently, this tick species has been reported in the" exact="United States," post="first observed to infest the sheep in New Jersey"/>
   <result pre="United States, first observed to infest the sheep in New" exact="Jersey" post="and then identified in seven states and the suburb"/>
   <result pre="regression tree (BRT) model that used SFTS infection data in" exact="China" post="and a range of environmental, climate and biological covariates."/>
   <result pre="the world. Briefly, the report data of SFTS patients in" exact="China" post="was extracted from the China Information System for Diseases"/>
   <result pre="data of SFTS patients in China was extracted from the" exact="China" post="Information System for Diseases Control and Prevention (CISDCP). The"/>
   <result pre="The data on the SFTS patients in South Korea and" exact="Japan" post="were obtained from the Korea Centers for Disease Control"/>
   <result pre="(https://www.cdc.go.kr/) and the National Institute of Infectious Diseases (NIID) of" exact="Japan" post="(https://www.niid.go.jp/), both supplemented by data in the published literature"/>
   <result pre="396, and 866 cases who were respectively reported from China," exact="Japan" post="and South Korea, as well as 2 cases retrospectively"/>
   <result pre="rate (CFR) of 8.76%, with the highest CFR observed in" exact="Japan" post="(27.02%, 107/396). The age and gender pattern differed significantly"/>
   <result pre="significantly among the three major affected countries, with patients in" exact="China" post="having the lowest median age (62 years old), and"/>
   <result pre="or administrative regions was 25, 23 and 17 in China," exact="Japan" post="and South Korea, respectively. In two countries, the reported"/>
   <result pre="cases were geographically concentrated, basically in the eastern and central" exact="China" post="and the southern Japan, but distributed throughout South Korea"/>
   <result pre="1A). The disease epidemic spanned from May to July in" exact="China" post="and Japan, and from June to October in South"/>
   <result pre="each of three mainly affected countries by SFTS, including China," exact="Japan" post="and South Korea. The circumference is divided into 12"/>
   <result pre="1. Baseline demographic characteristics of reported SFTS patients in China," exact="Japan" post="and South Korea from 2010 to 2018. China Japan"/>
   <result pre="in China, Japan and South Korea from 2010 to 2018." exact="China" post="Japan South Korea No. of reported cases 11,995 396"/>
   <result pre="China, Japan and South Korea from 2010 to 2018. China" exact="Japan" post="South Korea No. of reported cases 11,995 396 866"/>
   <result pre="2A). The H. longicornis tick was first reported in central" exact="China" post="and eastern Russia in 1891, subsequently recorded from New"/>
   <result pre="central China and eastern Russia in 1891, subsequently recorded from" exact="New Zealand" post="and Japan in 1910s, from South Korea, and Australia"/>
   <result pre="eastern Russia in 1891, subsequently recorded from New Zealand and" exact="Japan" post="in 1910s, from South Korea, and Australia in 1960s,"/>
   <result pre="New Zealand and Japan in 1910s, from South Korea, and" exact="Australia" post="in 1960s, with the most recent report in 2010s"/>
   <result pre="the eastern and central China, the southeast Russia that bordered" exact="China" post="and North Korea, the whole country of North Korea,"/>
   <result pre="areas of Australia, the southwestern coastal and northern regions of" exact="New Zealand" post="and several Oceania countries/regions. It is notable that a"/>
   <result pre="coastal areas in northern and limited region in the southern" exact="New Zealand" post="(Figure 4). The receiver-operating characteristic (ROC) curve was produced"/>
   <result pre="receptivity to H. longicornis across two continents, including northeastern USA," exact="New Zealand," post="parts of Australia, and several Pacific islands (New Caledonia,"/>
   <result pre="needed moderate surveillance. A special situation was observed in the" exact="New Zealand," post="which had reported the presence of H. longicornis tick"/>
   <result pre="phase, with the first human infection reported in 2009 in" exact="China" post="[41]. The SFTSV viral lineage, if already existed in"/>
   <result pre="China [41]. The SFTSV viral lineage, if already existed in" exact="New Zealand," post="might remained unknown to cause human infection without adequate"/>
   <result pre="tests. On the other hand, the long distance between the" exact="New Zealand" post="and Asian countries, together with less population travel or"/>
   <result pre="and death in humans was isolated from patients in the" exact="United States" post="[42–44]. In case the HRTV could be also harboured"/>
   <result pre="Strong correlations have been found in Henan Province of central" exact="China" post="between SFTS risk and suitable environments for ticks, including"/>
   <result pre="to be associated with SFTS incidence in Hubei province in" exact="China" post="[50]. These findings corroborated the important role of these"/>
   <result pre="Guertu virus (GTV) from Dermacentor nuttalli ticks in Xinjiang Province," exact="China" post="[51], and Hunter island group virus (HIGV) isolated from"/>
   <result pre="and Hunter island group virus (HIGV) isolated from ticks in" exact="Australia" post="[52]. In addition to SFTSV, H. longicornis also transmits"/>
   <result pre="study was supported by the National Natural Science Foundation of" exact="China" post="(No. 81825019), the Special Program for Prevention and Control"/>
   <result pre="Special Program for Prevention and Control of Infectious Diseases in" exact="China" post="(No. 2018ZX10201001, 2018ZX10713002, 2018ZX10101003). The authors thank medical staff"/>
   <result pre="distribution of the tick, Haemaphysalis longicornis Neumann (Acari: Ixodidae) in" exact="New Zealand." post="N Z Vet J. 2016;64(1):10–20.25849758 14RaineyT, OcciJL, RobbinsRG, et"/>
   <result pre="Haemaphysalis longicornis (Ixodida: Ixodidae) parasitizing a sheep in New Jersey," exact="United States." post="J Med Entomol. 2018;55(3):757–759.29471482 15United States Department of Agriculture."/>
   <result pre="et al.Review of Haemaphysalis (kaiseriana) Longicornis Neumann (resurrected) of Australia," exact="New Zealand," post="New Caledonia, Fiji, Japan, Korea, and Northeastern China and"/>
   <result pre="of Haemaphysalis (kaiseriana) Longicornis Neumann (resurrected) of Australia, New Zealand," exact="New Caledonia," post="Fiji, Japan, Korea, and Northeastern China and USSR, and"/>
   <result pre="Australia, New Zealand, New Caledonia, Fiji, Japan, Korea, and Northeastern" exact="China" post="and USSR, and its parthenogenetic and bisexual populations (Ixodoidea,"/>
   <result pre="LakesT.Assessment of land use factors associated with dengue cases in" exact="Malaysia" post="using boosted regression trees. Spat Spatiotemporal Epidemiol. 2014;10:75–84.25113593 39PigottDM,"/>
   <result pre="al.Multistate infestation with the exotic disease-vector tick Haemaphysalis longicornis –" exact="United States," post="August 2017–September 2018. MMWR Morb Mortal Wkly Rep. 2018;67(47):1310–1313.30496158"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7245076/results/search/country/results.xml">
   <result pre="Sci. U.S.ApnaspnasPNASProceedings of the National Academy of Sciences of the" exact="United States" post="of America0027-84241091-6490National Academy of Sciences pmcid: 7245076 pmid: 32366663201919287"/>
   <result pre="virus SyeninaAyesaabhttps://orcid.org/0000-0003-3293-6279VijaykrishnaDhanasekarancGanEsther ShuyiaTanHwee ChengaChoyMilly M.aSiriphanitchakornTanamasadhttps://orcid.org/0000-0003-3560-072XChengColinaVasudevanSubhash G.ahttps://orcid.org/0000-0002-0520-1544OoiEng Eongabef1[], aDuke-National University of" exact="Singapore" post="Medical SchoolSingapore[], bNational University of SingaporeSingapore[], cMonash UniversityAustralia[], dNational"/>
   <result pre="of SingaporeSingapore[], eNational University of SingaporeSingapore[], fSingHealth Duke-National University of" exact="Singapore" post="Global Health InstituteSingapore 1To whom correspondence may be addressed."/>
   <result pre="epidemiologic fitness phenotype associated with the 1994 DENV2 outbreak in" exact="Puerto Rico." post="We found that five amino acid substitutions in the"/>
   <result pre="viral serotype or genotype. Such instances have been observed in" exact="Sri Lanka" post="(4), Puerto Rico (5), Singapore (6), Vietnam (7), Nicaragua"/>
   <result pre="genotype. Such instances have been observed in Sri Lanka (4)," exact="Puerto Rico" post="(5), Singapore (6), Vietnam (7), Nicaragua (8), Taiwan (9),"/>
   <result pre="have been observed in Sri Lanka (4), Puerto Rico (5)," exact="Singapore" post="(6), Vietnam (7), Nicaragua (8), Taiwan (9), and Brazil"/>
   <result pre="Sri Lanka (4), Puerto Rico (5), Singapore (6), Vietnam (7)," exact="Nicaragua" post="(8), Taiwan (9), and Brazil (10). In all of"/>
   <result pre="(5), Singapore (6), Vietnam (7), Nicaragua (8), Taiwan (9), and" exact="Brazil" post="(10). In all of these outbreaks, phylogenetic analyses grouped"/>
   <result pre="we have taken advantage of the 1994 dengue outbreak in" exact="Puerto Rico." post="In this outbreak, sequence data of the DENV genome"/>
   <result pre="reconstruction on the codon phylogenies of all DENV2s isolated from" exact="Puerto Rico" post="dating as far back as 1981. This was done"/>
   <result pre="phylogenetic tree based on codon genome of DENV2 circulating in" exact="Puerto Rico" post="between 1944 and 2010. Amino acid substitutions separating PR2A"/>
   <result pre="fitness have remained vague, however. The 1994 dengue epidemic in" exact="Puerto Rico," post="in which the emergence of a new clade of"/>
   <result pre="DENV. Our data collectively propose a model to explain the" exact="Puerto Rico" post="dengue outbreak in 1994. Mutations in the 3 ′UTR"/>
   <result pre="brief, viral RNA was extracted from strain PR1940 (representing the" exact="Puerto Rico" post="endemic clade PR1) and strain PR8541 (representing the Puerto"/>
   <result pre="Puerto Rico endemic clade PR1) and strain PR8541 (representing the" exact="Puerto Rico" post="epidemic clade PR2B) using the QIAamp Viral RNA Mini"/>
   <result pre="using Geneious 9.0.5 (48). Phylogenetic Analysis. Whole-genome sequences of the" exact="Puerto Rico" post="DENV2 were retrieved from the NIAID ViPR (18). The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7247121/results/search/country/results.xml">
   <result pre="administrative records from a pediatric HIV clinic in the southern" exact="United States" post="http://orcid.org/0000-0002-6716-9754BudhwaniHennabudhwani@uab.edu1MillsLori2MarefkaLauren E. B.2EadySequoya2NghiemVan T.1SimpsonTina2[1], grid.265892.20000000106344187Department of Health Care Organization"/>
   <result pre="evaluating data from a pediatric HIV clinic in the southern" exact="United States." post="Records from perinatal infected patients seen between 2008 and"/>
   <result pre="2000 of these children living with HIV reside in the" exact="United States" post="[1]. Addressing suboptimal rates of viral load suppression in"/>
   <result pre="period (2008–2018) at a pediatric HIV clinic in the southern" exact="United States" post="(n = 61). Although records were extracted from the clinic’s electronic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7256313/results/search/country/results.xml">
   <result pre="1CDCEstimated influenza illnesses, medical visits, hospitalizations, and deaths in the" exact="United States" post="— 2018–2019 influenza seasonRetrieved from:https://www.cdc.gov/flu/about/burden/2018-2019.html 2UyekiT.M.BernsteinH.H.BradleyJ.S.Clinical practice guidelines by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7259492/results/search/country/results.xml">
   <result pre="School of Public Health and Tropical Medicine, New Orleans, Louisiana," exact="United States" post="of America[2], Institute for Global Health and Infectious Disease,"/>
   <result pre="of North Carolina at Chapel Hill, Chapel Hill, North Carolina," exact="United States" post="of America[3], Department of Pathobiological Sciences, School of Veterinary"/>
   <result pre="School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana," exact="United States" post="of America[4], Center for Applied Malaria Research and Evaluation,"/>
   <result pre="School of Public Health and Tropical Medicine, New Orleans, Louisiana," exact="United States" post="of America[5], Center for Computation and Technology, Louisiana State"/>
   <result pre="for Computation and Technology, Louisiana State University, Baton Rouge, Louisiana," exact="United States" post="of AmericaSamyAbdallah M.Editor[], Faculty of Science, Ain Shams University"/>
   <result pre="Ae. albopictus from New Orleans to a Zika strain from" exact="Panama" post="after oral challenge. These results suggest a limited risk"/>
   <result pre="factors. For instance, one study found that hospitalized patients in" exact="Nicaragua" post="had higher viremia compared to non-hospitalized patients [10]. In"/>
   <result pre="though there was some limited susceptibility to infection by a" exact="Panama" post="strain of Zika virus. While there is limited chance"/>
   <result pre="albopictus from New Orleans to a Zika virus strain from" exact="Panama" post="after oral challenge with virus doses similar to that"/>
   <result pre="structure of a colonising species: Aedes albopictus (Skuse) in the" exact="United States." post="Heredity (Edinb). 1988;60 (Pt 2):173–81. Epub 1988/04/01. 10.1038/hdy.1988.29 .3366625"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7259881/results/search/country/results.xml">
   <result pre="2016 and 2017 in Lazio, an administrative region in central" exact="Italy" post="whose main city is Rome [17]. In this paper"/>
   <result pre="Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Slovenia, Slovakia, Spain," exact="Sweden" post="and the United Kingdom) was 4 475 (7 September"/>
   <result pre="been reported to be widely circulating among MSM [19]. In" exact="Italy" post="between 1 June 2016 and 31 March 2017 the"/>
   <result pre="cases value was described in 2012–2016. The M/F ratio in" exact="Italy" post="was 8.4 during outbreak period against 1.5 in 2012–2016"/>
   <result pre="were included in the phylogenetic analysis: VRD_521_2016, first described in" exact="United Kingdom," post="RIVM-HAV16-090 and RIVM-HAV16-069 first described in Netherlands, and V16_25801,"/>
   <result pre="RIVM-HAV16-069 first described in Netherlands, and V16_25801, first reported in" exact="Germany" post="[6, 18, 23]. For this dataset, the best fitting"/>
   <result pre="outbreak in MSM. Clade C has 18 sequences, 14 from" exact="Italy" post="(eight from Lazio), two from Algeria, one from Germany"/>
   <result pre="from Italy (eight from Lazio), two from Algeria, one from" exact="Germany" post="and one from Argentina, in which main node was"/>
   <result pre="MSM outbreaks were found between 2016 in England, Netherland and" exact="Germany" post="[18, 23, 68]. Two HAV strains VRD_521_2016 and RIVM-HAV16–090"/>
   <result pre="markers were found in other extra-EU countries, such as Israel," exact="Brazil" post="and Japan [69–72], while in some cases new local"/>
   <result pre="found in other extra-EU countries, such as Israel, Brazil and" exact="Japan" post="[69–72], while in some cases new local outbreaks among"/>
   <result pre="outbreaks among MSM were there [72–74]. In this epidemic event" exact="Italy" post="was no exception: since September 2016 Lazio Regional Service"/>
   <result pre="strains linked to same epidemic event were reported in southern" exact="Italy" post="[15]. Another important aspect was the possible geographic origin"/>
   <result pre="relative of this cluster was a sequence (AB020565) collected in" exact="Japan" post="in 1993 [75], suggesting a possible origin of the"/>
   <result pre="BDSKY in a Dengue virus outbreak in urban area of" exact="Brazil" post="in March 2012 coincided with the observed peak in"/>
   <result pre="1.6–2.2 [78]; in AHA outbreak at an elementary school in" exact="China" post="in 2011 R0 was estimated between 2.1 and 2.8"/>
   <result pre="the HAV outbreak occurred in a restricted geographical region of" exact="Italy" post="during 2016–2017, mainly affecting MSM, where two monophyletic strains"/>
   <result pre="obtained by Nextstrain, labelled by country. The sequences from Lazio," exact="Italy" post="are coloured in light green. (TIFF) LINK Click here"/>
   <result pre="from Lazio region, Italy, and 17 HAV sequences from Barcelona," exact="Spain" post="[55] (MK116906 to MK116923), using only 316 nt-long sequences"/>
   <result pre="Role of Sequencing to Trace Hepatitis A Viruses Circulating in" exact="Italy" post="During a Large Multi-Country European Foodborne Outbreak in 2013."/>
   <result pre="A involving HIV-infected men who have sex with men, Rome," exact="Italy" post="2008–2009. J Clin Virol. 2012;54(1):26–9. 10.1016/j.jcv.2012.01.00922341552 15MauroMV, GrecoF, TenutaR,"/>
   <result pre="genomes of genotype IIIA Hepatitis A Virus strains (1995–2008) from" exact="India" post="and estimates of the evolutionary rates and ages. Infect"/>
   <result pre="10.1016/j.micinf.2014.01.00324486185 66CastkovaJ, BenesC. Increase in hepatitis A cases in the" exact="Czech Republic" post="in 2008—an update. Euro Surveill. 2009;14(3). 67VolzEM, KoelleK, BedfordT."/>
   <result pre="2016 affecting men who have sex with men (MSM) in" exact="Chile" post="connected to the current outbreak in MSM in Europe,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7263602/results/search/country/results.xml">
   <result pre="an adenovirus type 7 infection in a boot camp in" exact="China" post="An outbreak of adenovirus type 7 infection http://orcid.org/0000-0002-2784-2246GuoZuiyuanConceptualizationData curationFormal"/>
   <result pre="with adenovirus type 7 occurred in a boot camp in" exact="China" post="and was characterized by many cases, severe symptoms, and"/>
   <result pre="susceptible individuals. Funding http://dx.doi.org/10.13039/501100013076National Major Science and Technology Projects of" exact="China" post="2018ZX10713003http://orcid.org/0000-0002-2784-2246GuoZuiyuan The work was supported by National Science and"/>
   <result pre="adenovirus in the Chinese military in recent years is that" exact="China" post="has not yet included adenovirus vaccines in planned immunizations."/>
   <result pre="type 7d caused an acute respiratory disease outbreak in southern" exact="China" post="after a twenty-one year absence. Sci Rep. 2014; 4:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7263634/results/search/country/results.xml">
   <result pre="Antibodies : People and Places : Geographical Locations : Asia:" exact="China" post=": Biology and life sciences : Organisms : Viruses"/>
   <result pre="Flaviviruses: West Nile virus Emergence of Zika virus infection in" exact="China" post="Zika virus infection in China ZhouChuan-minData curationFormal analysisInvestigationMethodologySoftwareWriting –"/>
   <result pre="of Zika virus infection in China Zika virus infection in" exact="China" post="ZhouChuan-minData curationFormal analysisInvestigationMethodologySoftwareWriting – original draft1LiuJian-weiInvestigation1QiRuiInvestigationSoftware1FangLi-zhuFormal analysis1QinXiang-rongFormal analysis1HanHui-juFormal analysis1MoRong-canResources2YuHaoWriting"/>
   <result pre="273 healthy individuals were collected from Nanning City, Guangxi Province," exact="China" post="in March 2019. We found that 9.5% (26/273) and"/>
   <result pre="suggests ZIKV as a potential threat to public health in" exact="China" post="but also expands our knowledge of ZIKV epidemic regions"/>
   <result pre="Asia. Therefore, government officials, physicians and public health workers in" exact="China" post="need to pay attention to ZIKV infection cases. Funding"/>
   <result pre="study was supported by the National Natural Science Funds of" exact="China" post="(Nos. 31570167, 81971939) and Jiangsu province community development project"/>
   <result pre="virus, belonging to mosquito-borne Flavivirus, which was first discovered in" exact="Uganda" post="in 1947 from a sentinel febrile rhesus monkey[1,2]. ZIKV"/>
   <result pre="and Anopheles coustani served as ZIKV transmitting vectors [6–12]. In" exact="China" post="A. aegypti are found mainly distributed in the south,"/>
   <result pre="also identified that A. aegypti and A. albopictus mosquitoes in" exact="China" post="were capable of mediating ZIKV transmission whereas C. quinquefasciatus"/>
   <result pre="ZIKV (GZDJ1685) was isolated from C. quinquefasciatus mosquitoes in Southern" exact="China" post="[14]. About 2.6 billion people live in areas suitable"/>
   <result pre="view of recent advances of the ZIKV distribution model, Southeast" exact="China" post="was proven to be highly suitable for ZIKV transmission"/>
   <result pre="than 210 million people living in ZIKV suitable areas in" exact="China" post="[15,16]. Additionally, a large volume of travelers floated between"/>
   <result pre="large volume of travelers floated between different ZIKV-affected areas and" exact="China" post="each year [16]. Hence, China is becoming increasingly susceptible"/>
   <result pre="between different ZIKV-affected areas and China each year [16]. Hence," exact="China" post="is becoming increasingly susceptible and vulnerable to ZIKV. To"/>
   <result pre="except for a number of imported ZIKV infection cases in" exact="China" post="[17]. Therefore, in this study, we conducted a survey"/>
   <result pre="the Flavivirus genus. Discovery of ZIKV was first noticed in" exact="Uganda" post="in 1947, but only sporadic ZIKV infections were reported"/>
   <result pre="isolation of ZIKV from mosquitoes and travelers in Guizhou Province," exact="China" post="[6,14]. However, the existence of endemic ZIKV infection in"/>
   <result pre="China [6,14]. However, the existence of endemic ZIKV infection in" exact="China" post="was not reported up to date. In this study,"/>
   <result pre="that they're massively more likely that the ZIKV detected in" exact="China" post="is endemic. Additionally, Nanning City is located in the"/>
   <result pre="other words, the ZIKV infection cases in Vietnam, Laos, and" exact="Thailand" post="mainly concentrated on these countries’ southern regions and no"/>
   <result pre="in Vietnam [26]. Fig 3 ZIKV occurrence location records in" exact="China" post="and part of Southeast Asian countries including Vietnam, Laos,"/>
   <result pre="and part of Southeast Asian countries including Vietnam, Laos, Myanmar," exact="Cambodia" post="and Thailand; Red areas indicated ZIKV occurrence locations; The"/>
   <result pre="our study not only reported that distribution of ZIKV in" exact="China" post="is endemic but also broadened the area of ZIKV"/>
   <result pre="ZIKV infection in humans may distribute broadly from Guangxi Province," exact="China" post="to Southeast Asian countries. Further study is also necessary"/>
   <result pre="will alert government officials, physicians and public health workers in" exact="China" post="and Southeastern Asian countries to pay attention to ZIKV"/>
   <result pre="to ZIKV infections for travelers who have returned from Southern" exact="China" post="and Southeast Asia. The authors are grateful to Nanning"/>
   <result pre="1085–1091. 10.3201/eid2307.16152828430562 7LiMI, WongPS, NgLC, TanCH (2012) Oral susceptibility of" exact="Singapore" post="Aedes (Stegomyia) aegypti (Linnaeus) to Zika virus. PLoS Negl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7274467/results/search/country/results.xml">
   <result pre="Animals : People and places : Geographical locations : Africa:" exact="Central African Republic" post=": Earth Sciences : Geography : Human Geography: Human"/>
   <result pre="introduce a spatially explicit metapopulation model for rabies diffusion in" exact="Central African Republic." post="Calibrated on epidemiological data for the capital city, Bangui,"/>
   <result pre="estimated fluctuations of the incubation period in dogs. Applied to" exact="Central African Republic," post="our model indicates that continuous re-introductions of rabid dogs"/>
   <result pre="underlying key mechanisms to guide the implementation of elimination measures." exact="Central African Republic" post="reported an endemic circulation of canine rabies for at"/>
   <result pre="spatially explicit stochastic metapopulation model parameterized on the geography of" exact="Central African Republic" post="and calibrated on 20 years epidemiological data from Bangui."/>
   <result pre="develop a georeferenced discrete stochastic metapopulation epidemic model [50,51] for" exact="Central African Republic" post="where domestic dog habitats are represented by model patches"/>
   <result pre="To estimate the degree of urbanization of rabies epidemic in" exact="Central African Republic" post="compared to its dispersion in rural regions, we plot"/>
   <result pre="assess the impact of the landscape of human settlements in" exact="Central African Republic" post="and of human-mediated movements on the persistence of canine"/>
   <result pre="Domestic dogs’ spatial demographics and human-mediated movements Dog population in" exact="Central African Republic" post="is estimated to be of approximately 80,000 animals distributed"/>
   <result pre="in the center-east. Fig 1 Modeled domestic dog population in" exact="Central African Republic." post="A) Geographical distribution of the predicted dog subpopulations divided"/>
   <result pre="its surrounding region. The red circle defines Bangui’s neighborhood. The" exact="Central African Republic" post="borders were generated using data from &quot;Global Administrative Areas"/>
   <result pre="be located around Bangui). 10.1371/journal.pntd.0008317.t001Table 1 Modeled dog movements in" exact="Central African Republic." post="For each movement range we report the predicted number"/>
   <result pre="is predicted to remain endemic with high probability (≥80%) in" exact="Central African Republic" post="for R0≥1.01 and a large range of birth rate"/>
   <result pre="(R0≥1.12, Fig 3C). Fig 3 Dog rabies persistence probability in" exact="Central African Republic." post="A) Predicted persistence probability of rabies in the domestic"/>
   <result pre="persistence probability of rabies in the domestic dog population of" exact="Central African Republic" post="as a function of the basic reproductive number R0"/>
   <result pre="0.7,p&amp;lt;10−6, Fig 5C). Fig 5 Dog rabies endemic prevalence in" exact="Central African Republic." post="A) Geographical representation of the predicted dog rabies endemic"/>
   <result pre="(ECC) for rabies prevalence in the domestic dog population in" exact="Central African Republic." post="ECC is used to address the relative contribution of"/>
   <result pre="density and low density areas to endemic infection [68]. The" exact="Central African Republic" post="borders and administrative areas were generated using data from"/>
   <result pre="interventions for a sustainable elimination of dog rabies. Focusing on" exact="Central African Republic" post="where the virus has been endemic in the domestic"/>
   <result pre="[18] and other capital cities, such as e.g. N’Djamena in" exact="Chad" post="[5,19], which suggested that importations might occur from the"/>
   <result pre="Further, our work clearly shows that persistence of rabies in" exact="Central African Republic" post="is favored by the non-trivial interplay of long-range movements"/>
   <result pre="have significant implications for the control of canine rabies in" exact="Central African Republic." post="The predictions indicate that sustainable elimination of the disease"/>
   <result pre="steady dog population sizes [17–19]. With no mass vaccination in" exact="Central African Republic," post="higher transmission scenarios and the fatality rate of the"/>
   <result pre="from a 2013 survey on human-mediated dog movements in the" exact="Philippines" post="[29]. While lack of data remains a limitation, our"/>
   <result pre="limited in Africa and, to our knowledge, not present in" exact="Central African Republic" post="[76]. Third, like other studies [83], our model did"/>
   <result pre="et al.Designing Programs for Eliminating Canine Rabies from Islands: Bali," exact="Indonesia" post="as a Case Study.RupprechtCE, editor. PLoS Negl Trop Dis.2013;7:"/>
   <result pre="WildeH, MeslinFX, SurosoT, WidarsoHS. The rabies epidemic on Flores Island," exact="Indonesia" post="(1998–2003).J Med Assoc Thail Chotmaihet Thangphaet. 2004;8711: 1389–93. 79RandallDA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7285603/results/search/country/results.xml">
   <result pre="of foot and mouth disease outbreaks in Amhara region of" exact="Ethiopia" post="in the period 1999 to 2016 AmanEndrisendrisaman63@gmail.com1http://orcid.org/0000-0003-0793-5960MollaWassiemollawassie@yahoo.com2GebreegizabherZelekemekzel150@gmail.com3JemberuWudu Temesgenwudutemesgen@gmail.com2[1], grid.442845.b0000"/>
   <result pre="and family Picornaviridae. FMD is a well-established endemic disease in" exact="Ethiopia" post="since it was first detected in 1957. This retrospective"/>
   <result pre="and temporal distribution of FMD outbreaks in Amhara region of" exact="Ethiopia" post="using 18 years (January 1999–December 2016) reported outbreak data. Results"/>
   <result pre="of 636 FMD outbreaks were reported in Amhara region of" exact="Ethiopia" post="between 1999 and 2016 with an average and median"/>
   <result pre="considered for the long-term control of FMD. Keywords Amhara region" exact="Ethiopia" post="FMD Outbreak Spatial Temporal Background Foot and mouth disease"/>
   <result pre="Serotype C occurrence was reported for the last time in" exact="Kenya" post="in 2004 and in Ethiopia in 2008 [7, 8]."/>
   <result pre="for the last time in Kenya in 2004 and in" exact="Ethiopia" post="in 2008 [7, 8]. In Ethiopia, FMD is a"/>
   <result pre="recent times, there is an interest to control FMD in" exact="Ethiopia" post="to boost its live animal and meat exports as"/>
   <result pre="of FMD in endemic developing countries in general and in" exact="Ethiopia" post="in particular is not an easy task due to"/>
   <result pre="advocate that the control of FMD in endemic countries like" exact="Ethiopia" post="has to be carried out in a long-term progressive"/>
   <result pre="program, which is a part of progressive control pathway (PCP)." exact="Ethiopia" post="has been identified to be in stage one of"/>
   <result pre="of 636 FMD outbreaks were reported in Amhara region of" exact="Ethiopia" post="between 1999 and 2016 with an average and median"/>
   <result pre="for Orthodox Christians in Amhara region in particular and in" exact="Ethiopia" post="in general. Similarly, peak FMD outbreaks coinciding or following"/>
   <result pre="special holidays have been observed in endemic countries such as" exact="Sri Lanka." post="This has been related to animal transports in response"/>
   <result pre="the Amhara region, subsequent study needs to be undertaken in" exact="Ethiopia" post="in general to have a good insight in the"/>
   <result pre="Study area The study was conducted in Amhara region of" exact="Ethiopia" post="(Fig. 6). The Amhara region is located in the"/>
   <result pre="Amhara region is located in the north western part of" exact="Ethiopia" post="between 9°20′ and 14°20′ North latitude and 36° 20′"/>
   <result pre="over 2000 mm in the West [28]. Fig. 6 Map of" exact="Ethiopia" post="showing the study area Amhara region with administrative zone"/>
   <result pre="on the 2007 census of the central statistical agency of" exact="Ethiopia" post="(CSA), the Amhara region has a population of 17,221,976"/>
   <result pre="of Amhara region and the Federal Veterinary Epidemiology Directorate of" exact="Ethiopia" post="for the period 1999–2016. The regional and the federal"/>
   <result pre="8.RufaelTCatleyABogaleASahleMShiferawYFoot and mouth disease in the Borana pastoral system, southern" exact="Ethiopia" post="and implications for livelihoods and international tradeTrop Anim Health"/>
   <result pre="transmission dynamics of foot and mouth disease in Amhara region." exact="Ethiopia" post="Prev Vet Med. 2019; 10.1016/j.prevetmed.2019.04.002. 22.PeraltaEACarpenterTEFarverTBThe application of time"/>
   <result pre="disease under three different strategies of control and eradication in" exact="Colombia" post="(1982–2003)Vet Vet Res Com200731819834 24.Rosenberg FJ, Astudillo V. Evaluation"/>
   <result pre="of alternative strategies for foot and mouth disease control in" exact="Paraguay" post="In: New techniques in Veterinary Epidemiology and Economics. In"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7286386/results/search/country/results.xml">
   <result pre="overall and 89.1% (40.8–91.6%), 65.6% (61.3–69.6%), and 79.2% (45.4–84.1%) for" exact="Sierra Leone," post="Guinea, and Liberia, respectively. We found that district, hospitalisation"/>
   <result pre="% (95% CI) Adjusted CFR With Imputation, % (95% CI)" exact="Guinea" post="3740 3757 65.8 (61.6–69.9) 65.6 (61.3–69.6) 65.6 (61.3–69.6) Liberia"/>
   <result pre="CI) Guinea 3740 3757 65.8 (61.6–69.9) 65.6 (61.3–69.6) 65.6 (61.3–69.6)" exact="Liberia" post="4624 8130 71.7 (67.2–75.6) 69.7 (55.6–78.7) 79.2 (45.4–84.1) Sierra"/>
   <result pre="(61.3–69.6) Liberia 4624 8130 71.7 (67.2–75.6) 69.7 (55.6–78.7) 79.2 (45.4–84.1)" exact="Sierra Leone" post="10 280 21 451 81.3 (79.3–83.3) 74.6 (52.2–84.3) 89.1"/>
   <result pre="probable and suspected cases&quot;). Abbreviations: CFR, case fatality ratio; S/Leone," exact="Sierra Leone." post="CFR estimates increased with increasing reporting delays. The lowest"/>
   <result pre="73.5–76.9%) unadjusted and without imputation, respectively (Table 1, Figure 3)." exact="Guinea" post="had the lowest rates, with CFRs of 65.6% (95%"/>
   <result pre="and 71.7% (95% CI, 67.2–75.6%) unadjusted and without imputation, respectively." exact="Sierra Leone" post="had the highest rates, with CFRs of 74.6% (95%"/>
   <result pre="45.4–84.1%), and 89.1% (95% CI, 40.8–91.6%) for Guinea, Liberia, and" exact="Sierra Leone," post="respectively (Table 1). In Table 3, we found that"/>
   <result pre="have a predictive value in an earlier study conducted in" exact="Sierra Leone" post="[22], although larger sample sizes would be needed to"/>
   <result pre="3 countries. The relatively high adjusted CFR estimates obtained in" exact="Liberia" post="and Sierra Leone compared with estimates without and with"/>
   <result pre="The relatively high adjusted CFR estimates obtained in Liberia and" exact="Sierra Leone" post="compared with estimates without and with imputation, and the"/>
   <result pre="also possibly the changing data-collection practices over time. For instance," exact="Liberia" post="switched from an aggregate system of reporting to an"/>
   <result pre="and risk factors for fatal Ebola virus disease, Moyamba District," exact="Sierra Leone," post="December 2014–February 2015. Emerg Infect Dis2016; 22:1537.27268303 4.FocosiD, MaggiFEstimates"/>
   <result pre="factors of 139 patients with Ebola virus disease in western" exact="Sierra Leone." post="Am J Infect Control2016; 44:1285–90.27317404 23.DallatomasinaS, CrestaniR, Sylvester SquireJ,"/>
   <result pre="et al.Clinical features of patients with Ebola virus disease in" exact="Sierra Leone." post="Clin Infect Dis2015; 61:491–5.25995207 26.FrancicaJR, Varela-RohenaA, MedvecA, PlesaG, RileyJL,"/>
   <result pre="Neurol2015; 8:S4–S11.25992182 31.McNamaraLA, SchaferIJ, NolenLD, et al.Ebola surveillance—Guinea, Liberia, and" exact="Sierra Leone." post="MMWR Suppl2016; 65:35–43.27389614 32.GhaniAC, DonnellyCA, CoxDR, et al.Methods for"/>
   <result pre="in a Medecins Sans Frontieres Ebola case management centre, Kailahun," exact="Sierra Leone," post="June–October 2014. J Infect Dis2015; 212:1752–8.26002981"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="epidemic50noCov/PMC7291685/results/search/country/results.xml">
   <result pre="Fund page-count: Hepatitis B virus (HBV) infection declined in the" exact="United States" post="after implementing an effective vaccination protocol in the early"/>
   <result pre="men, is the most frequent HBV infection route in the" exact="United States" post="[1]. A recent national study highlighted the high prevalence"/>
   <result pre="for Disease Control and Prevention. Surveillance for viral hepatitis –" exact="United States," post="2017 Available at: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Accessed 4 February 2020. 2.collab:"/>
   <result pre="deaths involving heroin, by Race/Ethnicity† — National Vital Statistics System," exact="United States," post="1999–2017. MMWR Morb Mortal Wkly Rep2019; 68:810.31536483 9.YeoYH, LeMH,"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
